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 “Each single action, recommendation or quick procedure, no matter 
how small these things are for us, they so naturally accumulate that we 
no longer even realise that we are experiencing an intervention and 
what the side effects are.” (Schwarz, Stahl 2011: 8) 
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ABSTRACT 
Background and aim: Delayed labour refers to progress that is slower than 
what is considered normal and the most common cause of delayed progress is 
inadequate uterine contractions. It primarily affects nulliparous women and is 
associated with childbirth complications and negative birth experiences, both 
of which can have an impact on future pregnancy and labour. Delayed labour 
is one of the main reasons for the overall increase in the rate of caesarean 
section (CS) in nulliparous women. Infusion with synthetic oxytocin is a 
treatment commonly used to enhance uterine contractions in delayed labour, 
with the aim of achieving a spontaneous vaginal birth. Despite widespread 
oxytocin use, no consensus exists regarding the dosage. Together with an 
increase in the use of oxytocin to accelerate labour progress, the incidence of 
CS due to delayed labour is steadily increasing. The overall aim of the studies 
in this thesis was to investigate risk factors, the use of oxytocin and outcomes 
related to a delayed labour progress. 
Methods: Two data collections (Studies 1 and 2) were performed, resulting in 
Papers I-IV. The first two papers (I-II) were based on a retrospective 
observational study (Study 1) in which 2,000 birth records from 2000-2001 
were scrutinised. In Paper I, both nulliparous and multiparous women with a 
spontaneous or induced onset of labour were included. Risk factors for delayed 
labour, frequency of interventions and outcomes were analysed in 1,480 
women. In Paper II, oxytocin use in 1,263 nulliparous and multiparous women 
with spontaneous onset of labour was analysed further. Multiparous women 
without previous vaginal delivery (n=35) were excluded. Papers III and IV 
were based on a double-blind, randomised, controlled trial (RCT) (Study 2) in 
which infusion with a high dose of oxytocin was compared with a low dose for 
augmentation of delayed labour in nulliparous women with spontaneous onset 
of labour. The hypothesis was that a high-dose regimen, compared with a low-
dose regimen, would reduce the number of CSs without negative maternal and 
neonatal outcomes. In Paper IV, experiences of childbirth and of labour pain 
in the two randomised groups were compared via the Childbirth Experience 
Questionnaire (CEQ) sent out one month after birth. The primary outcomes 
were CS rate (Paper III) and childbirth experience measured with the three 
domains of the CEQ: Own capacity; Perceived safety; and Participation (Paper 
IV). 
Results: Delayed labour occurred in 21% of all births and the main observed 
risk factors were nulliparity and multiparity without previous vaginal birth, 
epidural analgesia (EDA), gestational age ≥ 42 weeks and birth weight > 4,000 
grams (Paper I). Among nulliparous and multiparous women with 
spontaneous onset of labour, oxytocin was administered in 72.8% and 38.1 % 
respectively, but, for the majority, the criteria indicating delayed labour were 
 not met. Oxytocin augmentation was also undertaken in an unstructured 
manner. The frequency of operative births (instrumental vaginal birth and CS) 
in nulliparous women was higher for oxytocin recipients with delayed labour 
than for oxytocin recipients without delayed labour (40.9% versus 13.6%; 
p<0.001) (Paper II). Augmentation with a high dose of oxytocin did not lower 
the CS rate in nulliparous women with spontaneous onset of labour, compared 
with a low dose, despite a higher total dose and higher dose increment. More 
events with tachysystole together with signs of fetal distress occurred with a 
high-dose regimen, but there were no differences in neonatal outcomes. (Paper 
III). Childbirth experiences in the three domains did not differ between the 
randomised groups but were associated with mode of birth (Paper IV). 
Conclusion: The retrospective observational study found that nulliparous 
women ran an increased risk of delayed labour and operative birth 
(instrumental vaginal birth and CS). Multiparity without previous vaginal birth 
was also a risk factor for delayed labour and CS. As a result, a CS in a first 
birth might increase the risk of delayed labour and operative birth in a 
following labour. Oxytocin augmentation was used in an incorrect manner, 
both in excessive doses and by administration “too early or too late”. The RCT 
showed that a high dose of oxytocin was not superior to a low dose in terms of 
intrapartum CS outcome. As more tachysystole together with suspicious or 
pathological fetal heart rate occurred with a high-dose regimen and childbirth 
experience did not differ between the high- and low-dose groups, a low-dose 
oxytocin regimen is recommended for the treatment of augmentation of labour. 
Keywords: delayed labour, oxytocin use, caesarean section, childbirth 
experiences 
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SAMMANFATTNING PÅ SVENSKA 
När en förlossning går långsammare än förväntat eller progressen helt 
avstannar benämns detta oftast som ”förlängd förlossningsprogress” eller 
”långsam förlossning”. I svenskt språkbruk används mestadels ordet ”värk-
svaghet” för att beskriva när förlossningen inte går framåt som förväntat. Inom 
förlossningsvården är en förlängd förlossningsprogress ett vanlig före-
kommande problem, som främst drabbar förstföderskor och som är förenat 
med ökad risk för komplikationer som operativ förlossning med kejsarsnitt 
eller sugklocka och en negativ förlossningsupplevelse. Behandlingen av 
förlängd progress är huvudsakligen inriktad på att stimulera värkarbetet med 
infusion av syntetiskt oxytocin, för att normalisera förlossningsprogressen och 
uppnå en spontan vaginal förlossning. Trots att användningen av oxytocin för 
värkstimulering har ökat, är andelen operativ förlossning fortsatt hög bland 
kvinnor med förlängd progress.   
Det övergripande syftet med avhandlingsarbetet var att undersöka riskfaktorer 
och förlossningsutfall vid förlängd förlossningsprogress, samt att undersöka 
handläggning av värkstimulering med oxytocin under förlossning.  
Två datainsamlingar har genomförts (Studie 1 och 2). Studie 1 var en 
retrospektiv observationsstudie med granskning av förlossningsjournaler av-
seende riskfaktorer, handläggning av värkstimulering med oxytocin och 
förlossningsutfall i relation till en förlängd förlossningsprogress. Detta 
genererade två delarbeten (delarbete I och II). I delarbete I ingick både 
förstföderskor och omföderskor med spontan start eller induktion. I delarbete 
II ingick kvinnor (förstföderskor och omföderskor) med spontan 
förlossningsstart. Kvinnor med induktion och omföderskor utan tidigare 
vaginal förlossning exkluderades. Studie 2 var en dubbelblind, randomiserad, 
kontrollerad interventionsstudie där behandling med hög- alternativt lågdos 
oxytocin vid förlängd förlossningsprogress utvärderades. Studie 2 genererade 
delarbete III och IV. I delarbete III och IV ingick förstföderskor med spontan 
förlossningsstart. Hypotesen var att hög dos oxytocin ger färre akuta kejsarsnitt 
än låg dos utan att påverka förlossningsutfallet eller förlossningsupplevelsen 
inklusive upplevelse av smärta. I delarbete IV studerades 
förlossningsupplevelsen i de två randomiserade grupperna via ett validerat 
frågeformulär (Childbirth Experience Questionnaire, CEQ) en månad efter 
förlossningen samt även specifikt upplevelsen av smärta direkt efter 
förlossningen och en månad efter. Den primära utfallsvariabeln i delarbete III 
var akuta kejsarsnitt och i delarbete IV förlossningsenkätens (CEQ) tre 
dimensioner: Egen kapacitet, Trygghet och Delaktighet. 
 Resultatet visade att riskfaktorer för förlängd förlossningsprogress var att vara 
förstföderska, omföderska utan tidigare vaginal förlossning, användning av 
EDA både i tidigt skede (cervix öppningsgrad ≤ 5 cm) och i senare skede 
(cervix öppningsgrad > 5 cm) av förlossningen, graviditetslängd ≥ 42 veckor, 
samt en födelsevikt hos barnet på > 4000 gram. Akut kejsarsnitt och sugklocka 
förekom i högre grad hos kvinnor med en förlängd förlossningsprogress (38.6 
%) jämfört med kvinnor med en normal progress (6.4 %) (delarbete I). Det 
förekom en kraftig överanvändning av oxytocin för värkstimulering, samt 
felbehandling med både ”för tidig” och ”för sen” insättning av läkemedlet i 
relation till diagnostiserad förlängd progress. Trots oxytocinbehandling vid en 
förlängd progress, var frekvensen av akut kejsarsnitt hög hos förstföderskor, 
17.1% jämfört med 2.3 % för kvinnor i gruppen med normal progress 
(delarbete II). Behandling med hög dos oxytocin gav inte färre akuta 
kejsarsnitt. Förlossningslängden var 23 minuter kortare vid högdosbehandling 
och det förekom fler överstimuleringar med fosterljudspåverkan vid 
högdosbehandling, även om det inte var skillnad i neonatalt utfall. (delarbete 
III).  Det fanns inte heller någon skillnad i förlossningsupplevelse (CEQ) 
mellan de två randomiserade grupperna. En subgruppsanalys av hela gruppen 
visade att kvinnor vars förlossning avslutats operativt (kejsarsnitt eller 
sugklocka) skattade förlossningsupplevelsen mer negativt jämfört med 
kvinnor med spontan vaginal förlossning (delarbete IV). 
Sammanfattningsvis visar avhandlingsarbetet att en förlängd förlossnings-
progress var ett vanligt förekommande problem hos förstföderskor och innebar 
en ökad risk för operativ förlossning (kejsarsnitt och sugklocka). Detta bör 
särskilt beaktas då en komplicerad första förlossning kan öka risken för både 
medicinska och psykologiska konsekvenser inför en eventuell nästkommande 
förlossning. Behandling med oxytocin genomfördes på ett ostrukturerat sätt 
och följde inte de rådande riktlinjerna, vilket resulterade i att kvinnor utsattes 
för både onödig behandling och felbehandling. En hög dos oxytocin i 
värkstimulerande syfte gav inte färre akuta kejsarsnitt hos förstföderskor än 
behandling med låg dos och påverkade inte förlossningsupplevelsen jämfört 
med lågdosbehandling. Högdosbehandling gav fler överstimuleringar med 
fosterljudspåverkan, och studien visade inga fördelar av att rutinmässigt 
behandla med hög dos oxytocin vid en förlängd progress. I det kliniska arbetet 
på förlossningsavdelningen bör rutiner för värkstimulering med oxytocin 
kontinuerligt följas upp och diskuteras för att minska onödiga interventioner. 
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PREFACE 
I have spent virtually my entire professional life as a midwife on the labour 
ward at the NU Hospital Group (apart from nine years in the Amazonas region 
in Peru working on preventive health care). Being involved in and accom-
panying a women and her partner through a life event like childbirth still feels 
like a privilege. What is more, being given the opportunity to conduct research 
on a subject of interest has been thrilling. 
Two circumstances have influenced my choice of research. First in 1997, the 
delivery wards from two different hospitals with different working cultures 
were merged (one of them was the NU Hospital Group). Two work 
environments intersected, with different procedures and different approaches. 
We were all influenced by our previous working culture and some of us were 
more influenced by the active management-of-labour approach, while others 
were more influenced by a more expectant approach. Secondly, I had been 
involved for several years in counselling women expecting their first child 
who had a fear of childbirth and pregnant women with a negative childbirth 
experience from a previous labour and birth. For many of these women with 
previous childbirth, the duration of labour had affected their birth experience. 
Labour that was both too short and too long had been a traumatic event and, 
instead of having positive memories, these women brought fear and worries 
into their new pregnancy and labour. Both these situations aroused my 
interest in increasing our knowledge of the occurrence of delayed labour and 
in investigating management during labour, especially with regard to 
oxytocin augmentation. I hope that my conclusions in this thesis could be 
useful in promoting the health of women in labour and also could add to a 
positive childbirth experience. 
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1 INTRODUCTION 
Defining what constitutes “normal birth” is not easy, because the limits of what 
is considered to be “normal” are changing, as history develops and between 
cultures. Today, the definition of “normal birth” is close to what is defined as 
“natural”, even though both interventions with pharmacological analgesia and 
augmentation of labour are used.  
The most important criterion for a normal birth has been summarised by the 
World Health Organisation (WHO) and by SFOG in Sweden in a state-of-the-
art document and is defined as:  
Low-risk singleton pregnancy with spontaneous onset of 
labour, low risk at the start of labour and remaining so 
throughout labour and birth. The infant is born spontaneously 
in the vertex position between 37+0 and 41+6 (weeks+days) 
of pregnancy. After birth, mother and infant are in good 
condition (1, 2). 
A consensus statement that defines normal labour from a physiological 
perspective has been developed in a Delphi study consisting of a group 
representing three US midwifery organisations and members representing 
childbirth advocacy and consumer groups (3). The concept of normal 
physiological birth describes the usual, functional processes of an organism: “A 
normal physiological labour and birth is one that is powered by the innate 
human capacity of the woman and fetus” (Kennedy 2015) (4). This definition 
is based on evidence that suggests that, when healthy women and fetuses are 
left undisturbed and supported in an adequate manner, they usually experience 
normal physiological labour and birth (4). 
1.1 Progress of labour 
Defining what constitutes a “normal duration of labour” is a challenge, as 
consensus on the definitions of the onset of the active phase and the duration 
of the different stages of labour is lacking (5). Fifty years ago, up to 24 hours 
was regarded to be a normal duration for nulliparous women, compared with 
12 hours today (5, 6). When considering labour progress, it is important to be 
able to distinguish what is normal and what is not, to be able to recognise the 
time for intervention (7). 
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In 1955, Friedman was the first to describe labour progress in a small group 
(n=100) of nulliparous women with a curve recording the status of cervix 
dilation throughout labour (8). The findings were plotted onto a schedule and 
formed a sigmoid shape, well known as the Friedman curve with a slow initial 
phase, the latent phase with a more rapid change in cervical dilation rate 
including cervical full dilation and the descent of the fetus. The latter phase 
was named the active phase of labour and starts, according to Friedman, when 
the cervix is dilated 2-2.5 cm and has an expected cervical dilation of 
approximately 1.5 cm per hour. Clinical practice norms have been strongly 
influenced by Friedman’s findings, even though a debate related to what the 
normal progress of labour is, has been going on at the same time (9). 
Subsequent studies have indicated that labour is slower than Friedman’s results 
indicate (9, 10). In the 1970s, Philpott and Castle suggested, according to their 
results, cervical dilation averaging one cm per hour in active labour and 
regardless of parity (10). Two decades later, Albers et al. showed that active 
labour in a low-risk population lasts considerably longer than Friedman’s norm 
and without increased morbidity. The mean 7.7 hours for length of the first 
stage of the active phase was for nulliparous women and 5.7 hours for 
multiparous women (5). A reassessment of the Friedman curve was made by 
Zhang et al. in 2002 with a study of 1,329 low-risk women in whom both 
cervical dilation was slower at the start of the active phase and the dilation rate 
did not include a deceleration phase (11). The results indicated that, the 
progress of labour is more consistent with the results of Albers et al. The 
findings from Zhang’s reassessment were confirmed in a large cohort of 
62,415 women in 2010 (12). According to the WHO in 2018, the duration of 
the active first stage (from 5 cm to full cervical dilation) is usually no longer 
than 12 hours for nulliparous women and no longer than 10 hours for 
multiparous women (5). 
1.1.1 First and second stage of labour 
Latent first phase 
Labour is usually divided into the first and second stage, where the first stage 
is further divided into the latent phase (or latent first phase) and the active 
phase (or active first phase) (5). The latent phase is characterised by irregular 
and more or less painful contractions, together with slow cervical dilation (5). 
The duration of the latent phase varies between women. According to 
Friedman, a prolonged latent phase is defined as longer than or equal to 20 
hours in nulliparous women and 14 hours in multiparous women (8). In 
Sweden a duration of the latent phase of more than 18 hours is regarded as 
prolonged (13). The WHO has stated that a latent phase of more than eight 
hours is prolonged (14). 
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Active first phase 
In the active phase of first phase of labour, contractions become more intense 
and longer, together with a more rapid change in cervical dilation and a descent 
of the fetal head (5). Defining the time point of transmission between the latent 
phase and the onset of the active phase of labour has been described as one of 
the most important judgements in maternity care and is essential in monitoring 
labour progress; both to warrant interventions and to avoid unnecessary 
interventions (15). However, the findings reported by Zhang et al. have shown 
that there may not need to be a specific time point for transmission to the active 
phase, that women may enter the active phase at different stages, mostly 
between 3 and 5 cm of dilation, and that the duration of progression varies 
from person to person during the active phase(11, 12). 
There are different guidelines to define the onset of the active phase of labour 
and some are presented below. 
Sweden: National Board of Health and Welfare 2001 (1) 
 Two of three criteria 
 Cervical dilation of 3-4 cm 
 Three or more regular contractions every 10 minutes 
 Rupture of the amniotic membranes 
Swedish Associations of Midwives and Swedish Society of Obstetrics and 
Gynaecology 2015 (revised recommendation) (16) 
 Cervical dilation of 4 cm or complete cervical effacement and 
dilation of more than one cm 
 Two or more regular, painful contractions every 10 minutes 
 Rupture of the amniotic membranes 
WHO 
 Cervical dilation of 3 cm 1994 (14) 
 Cervical dilation of 5 cm 2018 (5) 
American College of Obstetricians and Gynecologists 
 Cervical dilation of 3-4 cm 2003 (17) 
 Cervical dilation of 6 cm 2014 (18) 
United Kingdom, NICE guidelines 2014 (7) 
 Progressive cervical dilation from 4 cm 
 Regular painful contractions 
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Second stage of labour 
The second stage of labour is easier to define and refers to the duration from 
full cervical dilation to the birth of the child. The second stage starts with the 
descent of the fetal head, also called the passive stage, due to the absence of 
involuntary expulsive contraction. An active stage follows when the woman 
feels the urge to bear down or when the presenting part is close to or by the 
perineum. Consensus on what should be considered as a normal duration of the 
second stage also varies. (19). Swedish national guidelines define a normal 
descending phase with a duration of at least one hour and a bearing-down 
period of at least 30 minutes (20). 
1.1.2 The partogram 
A diagnostic tool for assessing labour progression 
Based on the Friedman curve, Philpott and Castle developed the partogram (or 
partograph), an instrument for midwives and obstetricians to monitor labour 
and to detect deviations in progress and in maternal or fetal well-being. The 
partogram contains an alert line, which represents a cervical dilation of one cm 
per hour. This was the modified mean rate of cervical dilation of the slowest 
10% of nulliparous women in the active phase in the study group of Philpott 
and Castle. To follow labour progress, information on cervical dilation is 
plotted on the partogram. An action line is placed after the alert line, usually 
after two or four hours. This will then process information when progress 
deviates from what is considered to be normal (1). 
The partogram is recommended by the WHO to be used in active labour in 
both low- and high-resource settings (14) and it is suggested to be the main 
labour record, reducing unnecessary duplication of documentation (21). 
The partogram appears to be widely accepted but with substantial differences 
in use (21). Critical opinions, however, mean that using the partogram can 
result in unnecessary interventions, reduce midwives’ autonomy and limit the 
opportunity to treat each woman as an individual, (22) while other evidence 
suggests that midwives find the partogram a useful practical tool, as it is easy 
to use, saves time, gives continuity of care and can be an educational means of 
assistance (23). 
Two systematic reviews assessed the benefits and harm of partogram use 
related to outcomes. Evidence from the RCTs suggests there are no differences 
in clinical outcome, such as caesarean section, instrumental vaginal birth or 
Apgar score at 5 minutes < 7, when a partogram is or is not used (21, 22). 
Lotta Selin 
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Zhang et al. have suggested a revised partogram for contemporary nulliparous 
women. This partogram differs from the partogram from the WHO because, 
based on its results, cervical dilation is not recorded as a continuous 
measurement and the 95th percentile lines, equivalent to the action line, are 
exponential stair-like lines rather than straight lines. The partogram of Zhang 
et al. allows a much slower labour progression of cervical dilation before 6 cm 
but a much shorter duration than four hours after 6 cm. As a result, the active 
phase of labour is not recommended to be defined before 6 cm of cervical 
dilation (12). The partogram proposed by Zang et al. is now being compared 
with the traditional four-hour action-line partogram in an ongoing multicentre-
cluster, randomised trial: the Labour Progression Study – LAPS, including 
nulliparous women with spontaneous onset of labour and with the primary 
endpoint of intrapartum CS (24). 
1.2 Delayed labour 
Delayed labour refers to a progress that is slower than what is regarded as 
normal and the most common cause of delayed labour is inadequate uterine 
contraction (6). It affects mainly nulliparous women and is one of the main 
causes of an adverse labour outcome such as caesarean section and 
instrumental vaginal birth (25). In the literature, slow progress is mostly 
described as labour dystocia, prolonged labour, delayed progress, failure to 
progress or delayed labour (26). One practical classification to categorise 
labour abnormalities is to describe them as slower than normal (protraction 
disorders) or the complete cessation of progress (arrest disorders) (27). 
1.2.1 Definition of delayed labour 
Delayed labour occurs and can only be defined during the active phase of 
labour (17). There is no common definition of delayed labour and the results 
presented in the literature can therefore be difficult to evaluate(1, 28). Despite 
the different definitions, they are all based on the same purpose for a decision 
to initiate intervention in clinical practice. 
The Swedish definitions of delayed labour and recommendations for the 
augmentation of labour from year 2001 were replaced in 2011. See the 
definitions below. 
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Swedish Society of Obstetrics and Gynaecology. Normal labour practice, 
2001 (1) 
 The active phase of first stage: Expected normal progress 
(mean cervical dilation one cm per hour) is protracted by two 
hours٭ 
 The second stage: Expected normal progress has lasted two 
hours 
*The definition is based on the two-hour action-line partogram 
 
National Swedish guidelines 2011 (20) 
 Active phase of first stage: Expected normal progress (mean 
cervical dilation one cm per hour) is protracted by three 
hours٭ 
 The second stage: Expected normal progress has ceased 
during the descending phase for at least one hour or the 
expulsive phase for 30 minutes 
*The definition is based on the three-hour action-line partogram 
 
According to the WHO, it is recommended that the diagnosis of delay in the 
first stage of labour should be based on a partogram, with a four-hour action- 
line (28). 
1.2.2 Delayed labour: risk factors and incidence 
Due to the lack of universal consensus of the definition of delayed labour, the 
incidence is not accurately known. Some evidence suggests that up to one in 
every five women experiences delay in labour (29). The incidence for 
nulliparous women has been reported to be as high as 44% in an English study 
and 37% in a Danish study both studies including healthy women with a 
normal pregnancy and spontaneous onset of labour (30, 31)  
It has been suggested that various factors influence labour progress negatively; 
they include nulliparous women, the premature rupture of membranes, 
induction, hypertensive disorder, hydramnios, gestational diabetes, (32) birth 
weight > 4,000 g, occiput posterior position, (33) gestational age ≥ 42 weeks, 
prolonged latent phase, high maternal age, (32, 34) high maternal BMI, use of 
epidural anaesthesia, (33) (34) women admitted in early labour (35). 
A long latent phase and few hours of rest and sleep during the preceding 24 
hours have been shown to extend active labour duration (36). The same study 
showed that food intake as usual during the preceding 24 hours was associated 
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with shorter labour duration. During the latent phase, women can feel distress 
and lose their confidence (37). Early labour assessment and support by 
professionals has shown, albeit with weak evidence, increased maternal 
satisfaction and reduction in interventions during labour, such as epidural 
analgesia and augmentation of labour with oxytocin, compared with immediate 
admission to hospital. There is, however, no consistency in the evidence to 
suggest whether healthy pregnant women should be encouraged to spend the 
latent phase at home (38). 
In a large retrospective cohort study of 11,368 women with a singleton 
pregnancy and spontaneous onset of labour, early admission (less than 4 cm 
cervical dilation) reduced the likelihood of giving birth within 12 hours of 
admission. In both nulliparous and multiparous women, early admission was 
associated with an increased likelihood of receiving oxytocin for augmentation 
and epidural analgesia for pain relief (39). This result is in agreement with 
earlier studies (35, 40, 41). 
Furthermore a multicentre cohort study of 2,810 nulliparous women in term 
spontaneous labour with a singleton infant in cephalic presentation revealed 
that the descent of the fetal head above the interspinal diameter, poor fetal 
head-to-cervix contact and dilation of the cervix of < 4 cm on admission were 
all obstetric risk indicators for delayed labour (34). 
Maternal fear and stress have been associated with delayed labour (42-44) 
labour, together with an increased rate of instrumental vaginal birth (44) and 
emergency caesarean section (43). Junge et al. found that women with a severe 
fear of childbirth used more anaesthetics for pain relief. Maternal mental health 
factors such as symptoms of depression and anxiety explained the association 
between severe fear of childbirth and labour pain (44). 
Epidural analgesia is a commonly used drug in labour and it is suggested that 
it is effective for pain relief (45), although the literature is inconsistent on the 
effects on labour progress and on maternal and fetal outcomes (34, 45). 
Delayed labour progress and an increased use of oxytocin in relation to 
epidural analgesia have been identified (46, 47).  The analgesia is given into 
the epidural space and acts mainly locally, but it also passes into the circulation 
and crosses the placenta.(48) Although only small quantities of the drug reach 
the maternal and fetal circulations after an epidural administration, (49) there 
are some concerns about possible adverse effects of the opioids (48, 50) 
Epidural opioids affect the Ferguson reflex in the late first and second stage of 
labour and the release of endogenous oxytocin due to the distension of the 
cervix and upper vagina will be inhibited. This then affects the urge to bear 
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down, which will be reduced (51) and may lead to delay in the second stage of 
labour, with a tendency towards more instrumental vaginal deliveries (52). 
Traditionally, higher doses of local anaesthetic were used, given as a motor 
blockade, which inhibited the woman’s mobility during labour (53). Today, 
lower concentrations of local anaesthetic are often given together with an 
opiate. Mobility is not affected, allowing women to move around during labour 
(45, 53). 
In a Cochrane report from 2011, updated in 2018, 40 randomised, controlled 
studies (11,000 women), all but apart from six studies, compared epidural 
analgesia with injected opioid drugs. Both the first and second stages of labour 
were longer for women with epidural analgesia compared with women in the 
opioid group and they were also more likely to have oxytocin augmentation 
(45). 
1.2.3 Delayed labour and adverse outcomes 
The steady global increase in caesarean section is a matter of great concern. 
During the last few decades from 1990-2014, an increase in the global average 
rate of CS from 6.7% to 19.1% has been reported. The highest CS rate (40.5%) 
was in Latin America and the lowest in Africa with 7.3%. In Europe, the 
average increase was from 11.2% to 25% (54). Compared with Swedish data, 
the caesarean section rate in singleton births was 5.3% in 1973 and 17.7% in 
2014. There was a difference in the caesarean section rate between the Swedish 
counties, from the lowest rate of 11.6% to the highest rate of 21.6% (55). 
Delayed labour is the most common reason for intrapartum caesarean section 
in nulliparous women (18, 42, 56, 57).  
Delayed labour has also been associated with an increased risk of instrumental 
vaginal births (31), postpartum haemorrhage (31, 58), infection (58), perineal 
trauma (58), heavily meconium-stained amniotic fluid (31) and a negative birth 
experience (59-61). The risk of serious, yet rare, maternal or neonatal 
morbidity has been shown to be steadily increasing with an increased second 
phase (62). 
Delayed labour in the first stage has been associated with maternal fever 
chorionamnionitis and endometritis (63-65). In a large cohort study, the 90th, 
95th and 97th percentiles for progress in the first stage of labour were 
compared in relation to outcomes. Longer labours were found to be associated 
with a prolonged second stage, maternal fever, shoulder dystocia, a 5-minutes 
Apgar score < 3, an arterial cord pH < 7.0 and a cord-base excess of >-12 and 
admission to the NICU (63). 
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There is no consistency in the evidence relating to the effect of delayed labour 
progress in the second stage on neonatal outcome (19). A prolonged second 
phase of three hours and more has been associated with an increased risk of a 
low 5-minutes Apgar score in non-instrumental labours of first-born infants 
and the rate of acidosis was increased in labours with a long pushing time (66) 
Another study found lower Apgar scores after one minute but not after five 
minutes (31). Findings from a recent study show an association between most 
of the adverse neonatal outcomes (such as low 5-minutes Apgar scores, birth-
asphyxia-related complications and admission to the NICU) with an increasing 
duration of the second stage. Umbilical artery acidosis increased with the 
duration of pushing but not with the duration of the second stage (55).However 
Menticoglou et al showed that a second stage of labour up to 5 hours could be 
allowed without adverse maternal or neonatal outcomes (67).  
Study results regarding adverse outcomes in labours related to a delayed 
second stage can be difficult to evaluate and factors other than the progress per 
se may have influenced the negative outcomes, i.e. the duration and rate of 
augmentation with oxytocin or the time for pushing (31, 68) In some cases, 
delayed labour as an indication for a caesarean section is not correct. In an 
article, Gifford states that delayed labour was commonly falsely diagnosed in 
the latent phase of labour and to early diagnosed in the second stage. At least 
16% of the women delivered by an intrapartum caesarean because of delayed 
progress were in fact in the latent phase (69). 
1.2.4 Prevention and treatment of delayed labour 
Endogenous oxytocin plays an important role in the physiological progress of 
labour. It is a peptide hormone, produced in the hypothalamus and released 
into the blood circulation in a pulsative manner. During labour, the release of 
oxytocin increases. It plays an important role during labour by stimulating the 
frequency and intensity of uterine contraction and cervical dilation. In addition, 
endogenous oxytocin has been shown to function as pain relief and reduce 
feelings of anxiety(70). Optimal physiological function enhances the release of 
endogenous oxytocin and beneficial catecholamines in response to stress (3). 
During labour, various non-invasive practices are used to relieve pain and to 
support the women to feel comfortable, safe and relaxed. These practices might 
promote the physiological process of a normally progressing labour by 
strengthening the release of endogenous oxytocin (25). 
Continuous support during labour  
Several studies have investigated continuous support during labour and its 
effect on labour outcome, as progress of labour, and women’s childbirth 
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experience. Continuous support refers to a person “who is present solely to 
provide support, is experienced in providing labour support, and has at least 
a modest amount of training (such as a doula)”. (Cochrane 2017) (71) 
Research shows that women value and benefit from the presence of a support 
person during labour and childbirth (52, 71). A woman’s own choice with 
regard to any person chosen by herself as a companion to assist her with 
continuous support throughout labour and childbirth is recommended by the 
WHO. and is seen as an important component of respectful maternity care, as 
well as being in accordance with a human rights-based approach (5). 
Continuous support given by a midwife has been shown to result in a shorter 
duration in both the first and second stage of labour (52). Continuous support 
by a doula (untrained lay person) throughout labour and childbirth has been 
assessed to give the most consistent and beneficial effects on childbirth 
outcomes (52). 
In a US randomised, controlled trial, participating middle-class women were 
supported by a male partner during labour and were fully educated about the 
process of labour. When additional support was provided by a doula, the 
likelihood of both caesarean section and the need for epidural analgesia 
decreased significantly (72). In a meta-analysis in 2012, Hodnett et al. reported 
a reduced duration of labour and a decreased risk of having a CS when 
continuous support was given compared with routine use (73).  
According to a recent systematic Cochrane review, (71) continuous support 
during labour may “shorten duration of labour, increasing spontaneous 
vaginal birth, decreasing caesarean birth, instrumental vaginal birth, use of 
any analgesia, use of regional analgesia, low five-minute Apgar score and 
negative feelings about childbirth experiences” (Cochrane 2017) 
Posture in labour 
In the active phase, in normal labour, women should be encouraged to adopt 
the position they find most comfortable (52). During the second stage, the use 
of any upright or lateral position compared with supine or lithotomy has been 
associated with a reduced duration of the second stage of labour (7, 52). In a 
study of labour augmentation and fetal outcomes in relation to birth positions, 
women allocated to a birth seat had a significantly shorter second stage, 
without affecting neonatal outcome negatively (74). In the same RCT, giving 
birth on a birth seat was not associated with adverse consequences for perineal 
outcomes (74). However a later population-based study indicates a higher risk 
of obstetric anal sphincter injury for parous women giving birth on a birth seat 
(probably for the reason that the expulsatory phase in parous women can be 
too rapid) (75). 
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Non-invasive practices for pain relief and relaxation 
The use of water for labour and giving birth in water (water immersion) is a 
widespread practice used for pain relief and relaxation. A recent Cochrane 
review in 2018 revised 15 trials with water immersion during both the first and 
the second phase of labour (76). The results of these trials show no differences 
in the duration of labour, which is in agreement with another study (77). There 
was no difference in mode of birth, but a reduced use of epidural/spinal 
analgesia and episiotomy with immersion in water compared with no 
immersion. Women undergoing immersion described increased satisfaction 
with their labour experience (76). The evidence level was assessed to be 
between moderate and very low. It was not possible to conclude whether the 
differences that were found were due to the water alone or due to the whole 
water-pool environment with a supporting caregiver nearby (76). 
A systematic review was conducted revising of seven double-blind RCT 
studies comparing sterile water injection with normal saline for women in the 
active phase of labour. Despite the fact that all the studies reported increased 
pain relief with sterile water injections, no meta-analysis was performed, due 
to the use of different scales and a failure to demonstrate a normal distribution 
of pain intensity or relief. As a result, no robust evidence that sterile water 
injection is effective as pain relief during labour could be presented. No 
differences were found in mode of birth. Information on labour duration or the 
use of epidural analgesia was not available (78). When comparing water 
injection with acupuncture, women receiving water injections were more 
satisfied with pain relief (79).  
Another review of 13 trials examined evidence supporting the use of 
acupuncture or acupressure for pain management (80). Single or limited 
numbers of trials reported less intense pain, increased satisfaction with pain 
relief, the reduced use of pharmacological analgesia and fewer instrumental 
births with acupuncture compared with placebo or usual care. Reduced pain 
intensity was also reported in women using acupressure. The active phase of 
labour was shorter in the acupuncture group compared with the control group. 
Length of labour from the initiation of acupuncture was significantly reduced 
by 71 minutes. There was a reduction of instrumental birth with acupuncture 
compared with standard care. Despite these findings, no general conclusions 
or recommendations for clinical practice could be drawn, due to the lack of 
high-quality trials, together with the small number of studies. There is still 
insufficient evidence relating to the treatment effect of acupuncture .(80).  
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Moreover, other practices used during labour are massage, hypnosis and 
different relaxation techniques, such as relaxation, yoga and music (81). A 
recent review reports that massage has given a major reduction in pain intensity 
and a reduced length of labour than usual care during the first stage of labour 
(82). The results of one study report that massage might help to relieve muscle 
spasm, give a sense of relaxation and reduce anxiety. The positive effects of 
massage may be an effect of the hormonal activation of endogenous oxytocin 
or the regulation of cortisol (70). Results have indicated that women 
participating in yoga have shorter labours compared with usual care or the 
supine position (81). Most of the non-pharmacological methods are non-
invasive and appear to be safe to use, for both mother and child, but their 
effectiveness is difficult to evaluate due to the limited high level of evidence 
(48). 
Inhaled analgesia such as nitrous oxide has been one of the most frequently 
used kinds of pharmacological pain relief (48). The literature suggests that 
nitrous oxide may offer safe, reasonably effective pain relief for women in 
labour. It could be an alternative for women who do not want a more 
pharmacologically invasive method (83). In a systematic review, with data 
from three studies, women during the first stage of labour reported less pain 
intensity from intermittent (self-administered) nitrous oxide, 50%, when 
compared with no analgesia. However, the quality of evidence was affected 
due to this unexplained heterogeneity and the result must therefore be 
evaluated with caution (48). 
Active management of labour  
The concept of the active management of labour was advocated almost five 
decades ago by O’Driscoll and colleagues to be used as a labour ward protocol 
for low-risk women in labour. The concept includes both non-invasive 
practices and more invasive methods. The purpose was to reduce the frequency 
of labours lasting more than 12 hours, which were defined as delayed labour, 
and accomplish a reduction in the high rate of intrapartum CS (84). Active 
management is a complex package of interventions and, in its original form, it 
includes antenatal education; one-to-one support in labour (continual presence 
of a nurse/midwife during labour); strict criteria for the diagnosis of labour; 
routine amniotomy when the active phase of labour is defined (uterine 
contraction together with cervical effacement); strict monitoring of progress in 
labour (e.g. by plotting on a partogram); vaginal examination every two hours; 
strict criteria for identifying slow progress and signs of fetal asphyxia; 
augmentation with oxytocin when labour progression was less than one cm of 
cervical dilation per hour; liberal use of analgesia and regular audit of operative 
births (6, 85). The different components of the concept have been modified 
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over time and the concept has been adopted worldwide, despite differing 
opinions regarding the effectiveness in reducing the CS rate (85). 
Amniotomy 
Amniotomy (artificial rupture of the amniotic membrane) is a common routine 
intervention to prevent (i.e. amniotomy performed early in labour with the aim 
to prevent delayed labour) or treat delayed labour. Amniotomy has been 
considered effective for women with delayed progress and reduces labour 
duration by between 60 and 120 min (52).  
Studies have compared routine amniotomy (i.e preventive treatment)) with 
conservative treatment (i.e. keep membrane intact as long as possible). In a 
meta-analysis of spontaneous labour, with routine amniotomy, no evidence 
was found of a shortening of the length of the first stage of labour or a decrease 
in CS rate when routine amniotomy was performed in comparison with 
keeping the membrane intact for as long as possible. In a further sub-group 
analysis of nulliparous women, however, labour duration decreased by 58 
minutes with amniotomy. No information regarding increased labour pain and 
amniotomy was found in the 14 included trials. Only two trials reported 
maternal satisfaction (86).  
In a recent RCT, nulliparous and multiparous women were randomised to 
either routine amniotomy by cervical dilation of 3, 4, and 5 cm or amniotomy 
performed as treatment in the event of delayed labour or signs of a need for 
surveillance of the fetus or at cervical dilation of 8 cm or more. The results 
showed a significantly shorter labour, reduced by just over two hours in the 
routine amniotomy group. Caesarean section did not differ between the two 
randomised groups and no negative fetal outcomes were found (87).  
An association between early amniotomy and adverse outcomes such as fetal 
heart deceleration, increased SC, fetal distress, infections and an increased risk 
of cord prolapse has been found (52). However this is not consistent with the 
findings from Smyth et al. (86). In spite of the common use of amniotomy to 
prevent delayed labour in clinical practice, there is no clear evidence that the 
potential benefits outweigh the potential harm (5) and the use of amniotomy to 
prevent delays in labour is not recommended by the WHO (28). 
1.2.5 Synthetic oxytocin for augmentation of labour 
Synthetic oxytocin was the first hormone to be isolated, sequenced and 
synthesised and it has been used clinically as an invasive pharmacological 
method in labour since the 1950s (88). The drug is used during labour to 
improve uterine contractions in delayed labour. In addition, it is used to induce 
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labour and used after birth to prevent haemorrhage (89). When used in delayed 
labour, the aim is to shorten labour duration to prevent adverse labour 
outcomes, such as instrumental vaginal delivery or CS (28). 
Infusion with synthetic oxytocin is now a common routine for augmentation 
of labour and one of the most frequently used medications in obstetric care 
(90). An accelerating trend towards using synthetic oxytocin in labour has been 
reported (68, 90). There is wide disparity in clinical use between countries and 
between hospitals in the same country (20, 90, 91). A study comparing 11 
hospitals in Sweden revealed large differences in overall oxytocin use, varying 
from 18.6% to 40.5% (68). Recent data from the Swedish Pregnancy Register 
from its annual report in 2016 report a large variation in oxytocin use between 
Swedish hospitals. (92). Considerable variation has also been reported in the 
dose of oxytocin, both initial doses and in the interval and frequency of dose 
increase (93). In Sweden, the document entitled Indication for augmentation 
with oxytocin during active labour (20) was published in 2011 with the aim of 
implementing evidence-based knowledge of oxytocin management and to 
reach a consensus between the Swedish labour wards in relation to oxytocin 
use. See Figure 1. 
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Figure 1. National Swedish guidelines 2011: Indication for augmentation 
with oxytocin during active labour (20) 
 
Three different regimens with oxytocin used to improve labour 
outcome  
It has previously been documented that oxytocin augmentation significantly 
reduces the overall length of labour (94-96). However, the effectiveness of 
oxytocin in treating abnormal progress and increasing the frequency of 
spontaneous vaginal birth is still unclear (25, 95, 97), and different regimens 
to improve labour outcome have been investigated. 
1. Trials with early or delayed oxytocin augmentation  
Trials including the whole concept of AML for the prevention of delay in the 
first stage of labour were studied in a Cochrane systematic review in 2013 (85) 
including more than 5,000 women. No evidence of a reduction in CS rate in 
the AML group compared with standard care was found (RR 0.88, 95% CI 
0.77-1.01). When data from one trial were excluded due to a large proportion 
of women being excluded after randomisation, a reduction in CS rate was seen 
 Oxytocin infusion 
 1 ml (8.3 microgram/ml=5 IU/ml) of oxytocin in 500 ml of 
normal saline (6 ml/h = 1 mU/min) Starting dose of 20 ml/h, 
increased by 20 ml at intervals of 20min 
The maximum dose is 180 ml/h 
 
Regimen 
 Amniotomy should be performed prior to the commencement 
of augmentation with oxytocin. 
 The dose should be adapted to individual responses and the 
minimum possible dose of oxytocin should be used, with the 
aim of normalising labour progress or achieving a maximum 
of four to five contractions every 10 min and with 40 s 
duration. 
 The duration of treatment should be at least four hours with  
optimal augmentation ( 4–5 contractions/10 min) before  
a new assessment of progress is made. 
 Continuous registration with CTG during time with 
augmentation and, in the event of any sign of tachysystole (> 
5 contractions/10 min) and/or signs of fetal distress such as 
abnormal cardiotocographic (CTG) pattern, the infusion 
should be decreased or discontinued. 
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for women in the AML group (RR 0.77, 95% CI 0.63-094). Labour duration 
was shorter in the AML group, even though there was a wide variation between 
the trials in the size of mean reduction from five minutes to up to two hours. 
No differences in negative fetal outcomes were seen and maternal satisfaction 
with childbirth experience was similar in the compared groups (85). Another 
systematic review comprised fourteen trials, of which four were within the 
AML concept. The effects of both early augmentation with amniotomy and 
oxytocin for the prevention of delay in labour and of therapy were studied. A 
reduction in labour duration was observed consistently across the trials and a 
modest reduction in the number of CS was seen in the prevention trials (98). 
 
A later systematic review of 1,338 trials compared the efficacy of 1) the use of 
oxytocin versus no use or placebo and 2) the early administration of oxytocin 
augmentation compared with the delayed administration of oxytocin. Oxytocin 
was used as a single agent for treating delayed labour. No effects were found 
on the CS rate in either groups but there was a reduction in labour duration of 
approximately two hours with early augmentation (97). In one of the trials, 
oxytocin was given after eight hours in cases of delayed augmentation (94). 
2. Partogram trials 
When comparing partograms with different action lines, more oxytocin was 
given with a two-hour action line compared with a four-hour action line. The 
caesarean section rate was lower when a four-hour action line was used 
compared with a three-hour action line (22). Evidence related to augmentation 
of labour based on the partograpm findings is limited (99).  
 
According to women’s preferences regarding the placement of the action line 
in relation to medical intervention, there are contradictory results. Older 
studies indicate that women are more satisfied with an early placement of the 
action line and early treatment with oxytocin (23, 100). More recent studies 
have indicated that women’s childbirth experiences did not differ in relation to 
the early or more expectant management of oxytocin use (101, 102). 
 
To summarise, when comparing early and delayed administration of oxytocin, 
it is important to take account of whether the early administration of oxytocin 
is a component in the whole package of AML or whether oxytocin is used as a 
single agent in the treatment of delayed labour. According to the Guideline 
Development Group (GDG) of the WHO in 2014, the positive effects on the 
CS rate in trials with an AML concept probably depend on the “continuous 
one-to-one care” component which has been shown to be the only component 
in the package that is beneficial (28). 
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3. Trials comparing high versus low doses of oxytocin for augmentation 
Two systematic reviews have studied delayed labour and treatment with a 
high-dose regimen compared with a low-dose regimen. In the review by Wei 
et al, (103) published in 2010, 426 studies of oxytocin treatment were 
identified. From these 426 studies, 10 RCTs, (with a total of 5,423 women) 
comparing a high- and low-dose regimen for augmentation of labour among 
women with a spontaneous onset of labour were included in the review. Only 
one of these studies was double blinded. A high dose was defined as a starting 
dose and an increment of ≥ 4 mU per minute. A low dose was defined as a 
starting dose and an increment of < 4 mU per minute. The increase in the 
interval was between 15 and 60 minutes. The high dose ranged between 4-10 
mU/min and the low dose ranged between 1-4 mU/min. In five of the included 
studies, the concept of AML (where a high dose of oxytocin was an integral 
part) was compared with usual care and with a low-dose regimen (103). 
 
In a Cochrane report by Mori et al. in 2011 (104) and in an updated version by 
Kenyon et al. in 2013 (105) of 16 studies, four studies (three RCTs and one 
quasi-RCT) with a total of 644 women with spontaneous onset of labour were 
revised. All the studies which were undertaken in the context of AML were 
excluded, justified by the difficulty involved in evaluating the dosage effect in 
the high-dose group. A high dose was defined as a starting dose and an 
increment of ≥ 4 mU per minute. A low dose was defined as a starting dose 
and an increment of < 4 mU per minute. The increase interval was between 15 
and 40 minutes. The high dose ranged between 4-7 mU/min and the low dose 
ranged between 1-2 mU/min. In both reviews, the primary outcome was the 
CS rate. See Table 1 for further information (104, 105). 
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Table 1. An overview of primary and secondary outcomes in two systematic reviews 
(Wei et al. 2010 and Kenyon 2013) (103, 105) comparing high versus low doses of 
oxytocin for the augmentation of labour 
 
Wei et al. 2010 
10 studies, 5,423 women 
 
 
Kenyon et al. 2013  
4 studies, 644 women 
 Caesarean section  
0.85 (0.75-0.97) 
10 studies, 5,423 women 
 
 
 
 
0.62 (0.44-0.86) 
4 studies, 644 women 
Instrumental vaginal 
birth 
1.00 (0.86-1.15) 
7 studies, 2,817 women 
 
 
 
0.83 (0.61-1.13) 
3 studies, 444 women 
 
 
Spontaneous vaginal 
birth 
1.07 (1.02-1.12) 
7 studies, 2,817 women 
1.35 (1.13-1.62) 
3 studies, 444 women 
Labour duration > 12h  0.46 (0.30-0.70)  
3 studies, 1,504 women 
 
Length of labour   -0.10 (-0.51-0.31) 
 1 study, 92 women 
Tachysystole 1.91 (1.49-2.45) 
5 studies, 1,446 women 
1.47 (0.73-2.94) 
4 studies, 644 women 
5-minute Apgar < 7 1.18 (0.61-2.28)  
6 studies, 2,163 women 
0.37(0.02-8.50)  
3 studies, 444 women 
Admission to NICU 1.05 (0.76-1.46)  
5 studies, 2,329 women 
0.50 (0.22-1.15)  
2 studies, 404 women 
The results are given as the risk ratio or mean difference (95% CI) 
 
Both reviews found that a high-dose regimen was associated with a statistically 
significant reduction in caesarean section, an increase in the frequency of 
spontaneous vaginal birth and shorter labours. Negative fetal outcomes were 
not associated with a high dose, even though more events with tachysystole 
were reported in the review by Wei et al. The results from Wei et al. suggest 
that the high-dose oxytocin might be more important in preventing caesarean 
section than the timing of the oxytocin intervention, (103) while the results 
from Kenyon et al. were considered to have a low evidence grade. Further-
more, a subgroup analysis of nulliparous women in the review by Kenyon et 
al. did not reveal any differences in CS rate between the two randomised 
groups (105). 
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Oxytocin and adverse neonatal outcomes  
During labour with increasing cervical dilation, the uterus becomes increa-
singly sensitive to the given dose of oxytocin, especially when the cervical 
dilation is 9-10 cm (52). When augmentation of labour with oxytocin is 
properly supervised, however, few side-effects will occur (89). Despite this, 
oxytocin administration has been associated with various negative effects, in 
particular an increased risk of uterine tachysystole (68, 106-110)  The violation 
of guidelines with regard to the use of oxytocin is probably one reason for 
adverse neonatal outcomes (68). Jonsson et al. have shown that a hyperactive 
uterine contraction pattern, usually caused by over-stimulation, is strongly 
associated with fetal distress and acidemia at birth (106, 108), something that 
has also been confirmed by others (107, 109, 110). In a Swedish study of severe 
asphyxia due to substandard care during labour, the incautious use of oxytocin 
was considered to be the cause of severe asphyxia in 71% of the cases (110).  
In the USA, a high frequency of obstetric malpractice claims has been 
associated with oxytocin use (107). Oxytocin has therefore been designated as 
a high-alert medication (111). Checklists and different standardised protocols 
have been recommended, with the aim of reducing adverse neonatal outcomes. 
They include a simple checklist-based protocol mainly assessing uterine 
response and fetal response to uterine contraction.(93, 107) Moreover, 
oxytocin augmentation has been associated with excessive pain, escalating the 
need for analgesia (112, 113) . 
1.2.6 Delayed labour and childbirth experiences 
Women’s experiences of childbirth are multifaceted and influenced by various 
factors (114) which can affect both following labours and life as a whole, in 
both a negative and a positive way (114-116). A systematic review by Shorey 
et al. found that a negative childbirth experience was associated with the 
decision both not to have another child and to delay the birth of a subsequent 
child. Maternal requests for caesarean section in a subsequent pregnancy were 
also seen more frequently together with a negative birth experience (117). In 
findings reported by Nystedt et al., one third of women with delayed labour 
had a negative childbirth experience and two-thirds stated that the experience 
had marked them for life. Labour pain experienced as worse than expected was 
the main factor that influenced the childbirth experience and women described 
feelings of being severely ill (59, 60). The association between delayed 
progress and labour pain leading to the greater use of epidural analgesia and 
an increased risk of operative intervention has been reported (31). An increased 
risk of negative and depressive memories has been seen in primiparous women 
with delayed progress one month after birth (102). Memories over time related 
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to pain experienced during labour appear to be strongly associated with 
women’s overall birth experience. For women with a negative birth 
experience, the pain score has been found to be high and unchanging years 
later, whereas, women with a positive birth experience have been associated 
with a lower pain score and the potential to forget labour pain over time (114, 
118). 
Delayed labour and factors, such as a persistent, intensive fear of childbirth, 
post-traumatic stress disorder and depression, have all been associated with a 
negative childbirth experience, sometimes as an isolated factor contributing to 
childbirth experience or interconnected with each other (119-121). One 
common finding is delayed labour and its relationship with adverse labour 
outcome such as instrumental vaginal birth, CS and negative fetal outcomes, 
with admission to the NICU. These are all factors that, in addition to delayed 
progress per se, have an influence on a negative childbirth experience (61, 114, 
122). 
In an interview study, women with delayed progress described feelings of loss 
of control, together with a distrust of their own body capacity (123). Another 
study by Hardin et al. of women undergoing planned unmedicated labour 
revealed that the ability for women to remain in control of their own birth, both 
physically and emotionally, was a strong factor for a positive birth experience 
(124). Perceived control during labour has been associated with childbirth self-
efficacy (125) and that findings reported by Stevens et al. suggest that a 
woman’s à priori preferences for control influence the relationship between 
perceived control of the birth environment and overall satisfaction with the 
childbirth experience (125). 
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2  RATIONALE 
Delayed labour is a common problem for women expecting their first child and 
represents an increased risk of negative outcomes for the mother and the 
newborn. Moreover, delayed labour is associated with a negative childbirth 
experience, which can influence the women’s daily life in the long-term 
perspective. 
In the 1960s, the Active Management of Labour (AML) model was launched 
in the belief that, among other things, the early use of oxytocin would lower 
the caesarean section rate related to delayed labour. But, a common problem 
in modern obstetric care, is the high frequency of delayed labour among 
nulliparous women, an excessive use of oxytocin augmentation and an 
increased frequency of caesarean section, mostly with the indication of delayed 
labour. It is important to reduce the numbers of CS, especially in nulliparous 
women with an uncomplicated pregnancy and spontaneous onset of labour. 
Studying management during labour may increase our knowledge of the 
intrapartum risk factors for delayed labour. For instance, the use of epidural 
analgesia and its influence on labour duration is the subject of debate. It is 
known that oxytocin shortens labour duration, but its effect on reducing the CS 
rate due to delayed labour is still unclear. Both knowledge and consensus 
regarding the dose of oxytocin for the augmentation of delayed labour are 
lacking. Women’s childbirth experiences and experience of labour pain related 
to the dose of oxytocin have not been studied sufficiently and, in addition, 
oxytocin has been designated as a high-alert medication due to its negative 
effects when not used in the appropriate way. 
Oxytocin use in clinical practice and in relation to delayed labour has not been 
sufficiently studied. The increased medicalisation of childbirth is a topic for 
discussion and observational studies can increase our knowledge of routines 
and compliance with guidelines. 
The foundation of knowledge derived from this thesis can optimise the quality 
of labour and childbirth care. In addition, an increased knowledge of women’s 
experiences of childbirth and labour pain related to the dose of oxytocin makes 
it possible to take account of not only obstetric outcomes when deciding on the 
appropriate treatment, but also women’s preferences. 
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3 AIMS 
3.1 Overall aim 
The overall aim was to investigate risk factors, the use of oxytocin and 
outcomes related to a delayed labour progress. 
3.2 Specific aims 
 To investigate obstetric risk factors, frequency of 
interventions and delivery outcomes for delayed labour (I) 
 
 To investigate the use of oxytocin for augmentation of labour 
and its relation to labour progress and delivery outcome (II) 
 
 To determine the optimal dose of oxytocin infusion with 
respect to efficacy and safety when treating delayed labour in 
nulliparous women (III) 
 
 To compare the childbirth experiences and experience of 
labour pain in primiparous women who had received high- 
versus low-dose oxytocin for augmentation of delayed labour 
(IV) 
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4 METHODS 
To realise the aims, we performed two data collections (Studies 1 and 2) with 
two papers in each (Papers 1-IV) The first study (Papers I-II) was performed 
in 2001 and 2002. The findings in Study 1 (Papers I-II) have shown to continue 
to be of major obstetric concern, even in recent years. This has prompted us to 
continue the research and deepen our investigation into oxytocin use, in 
relation to delayed labour and adverse labour outcomes in nulliparous women 
with spontaneous onset of labour (Study 2, Papers III-IV). An overview of the 
two studies with their respective papers (I-IV) included in the thesis is shown 
in Table 2. 
Table 2. Overview of the two studies (Papers I-IV) included in the thesis. 
 
 
Study Design Aim Analysis Population 
Study 1 
Papers 
I- II 
Retrospective 
observational 
study 
To investigate obstetric risk 
factors, frequency of 
interventions and delivery 
outcomes for delayed labour 
Descriptive and 
comparative 
statistics; 
multiple logistic 
regression 
Nulliparous and 
multiparous women 
with spontaneous 
onset of labour or 
induction  
To investigate the use of 
oxytocin for augmentation 
of labour and its  
relation to labour progress 
and delivery outcome 
Descriptive and 
comparative 
statistics 
Nulliparous and 
multiparous women 
with spontaneous 
onset of labour  
Study 2 
Papers 
III- IV 
Randomised, 
controlled trial 
To determine the optimal 
dose of oxytocin infusion 
with respect to efficacy and 
safety when treating 
delayed labour in nulliparous 
women 
Descriptive and 
comparative 
statistics;  
bootstrapping  
for calculation of 
difference 
between groups 
Nulliparous women 
with spontaneous 
onset of labour 
To compare the childbirth 
experiences and experience 
of labour pain in primiparous 
women who had received  
high- versus low- dose of 
oxytocin for augmentation 
of delayed labour  
Descriptive and 
comparative 
statistics   
Primiparous women 
with spontaneous 
onset of labour 
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4.1 Population, study design and data collection 
4.1.1 Study 1 (Papers I-II) 
Study 1 (Papers I-II) was designed as a retrospective observational study and 
was conducted at the NÄL Hospital (NU Hospital Group) in Trollhättan, 
Sweden. Data from 2,000 women were randomly collected from electronic 
antenatal and birth records (Obstetrics®) for two years, between 2000 and 
2001. The total number of births during this period was 5,702. 
The inclusion criteria were: 
 Nulliparous and multiparous women with a spontaneous or 
induced onset of labour 
 Gestational age of 37 completed weeks and more 
 Singleton gestation 
 Fetal cephalic presentation  
 A confirmed active phase of labour  
 Partogram and a cervix dilation of less than 7 cm on 
admission 
The active phase of labour and delayed labour in Study 1 (Papers I-II) were 
assessed and defined retrospectively during the data collection, by closely 
scrutinising every partogram. The definitions of the active phase of labour and 
delayed labour are shown in Figure 2. 
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Figure 2. Definitions of active phase of labour and delayed labour٭ 
 
Paper II comprised a subset of women from the data collection and consisted 
of nulliparous and multiparous women with spontaneous onset of labour. 
Multiparous women without a previous vaginal birth and women with 
induction were excluded. 
  
Active phase of labour 
 Regular painful contractions  
 An effaced cervix   
 Cervix dilation > 3-4 cm 
Delayed labour  
 First stage – based on the partogram alert and action line.  
A two-hour action line defined delayed labour. 
 Second stage – a delay of more than two hours 
*Based on the Swedish Society of Obstetrics and Gynecology: Normal labour practice, 
2001 (1) 
 
 
 
 
 
 
 
Delayed Labour-risk factors, use of oxytocin and outcomes 
28 
A flow diagram in Figure 3 is showing in  the selection procedure. 
Figure 3. Flow diagram Papers I-II 
 
Data collection 
Data from the obstetric records were imported in an Excel form and transported 
to SPSS for the analysis. The extracted maternal and fetal information 
comprised parity; defined delayed labour; maternal age; gestational age; 
epidural analgesia; oxytocin augmentation; mode of delivery; postpartum 
haemorrhage; perineal trauma (third- and fourth-degree lacerations); birth 
weight; Apgar score and umbilical cord arterial pH. In addition, the data 
extracted for Paper I were multiparity without previous vaginal birth; high-
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risk pregnancy; abnormal vertex presentation; induction of labour; time for 
amniotomy; retained placenta and, for Paper II, prolonged labour; duration 
from active phase of labour to defined delayed labour and oxytocin 
augmentation and administration of oxytocin (administered dose less than 
prescribed dose, prescribed dose administered, administered dose more than 
prescribed dose). 
High-risk pregnancy comprised women with diabetes prior to pregnancy and 
gestational diabetes, essential hypertension, pregnancy-induced hypertension, 
pre-eclampsia and obstetric and medical complications requiring bed rest. 
Epidural analgesia was analysed for epidural analgesia administered at both 
cervix dilation of ≤ 5 cm and cervix dilation of > 5 cm. 
4.1.2 Study 2 (Papers III-IV) 
Study 2 (Papers III-IV) was designed as a multicentre, double-blind, 
randomised, controlled trial which was carried out at four hospitals comprising 
six labour wards in Sweden: Sahlgrenska University Hospital (SU) in 
Gothenburg (SU-East and SU-Mölndal); Stockholm South General Hospital 
(SÖS and South BB); NU Hospital Group in Trollhättan and Uppsala 
University Hospital between September 2013 and October 2016. The wards 
entered the study at different time points.  
The inclusion criteria were: 
 Healthy* nulliparous women with a spontaneous onset of 
labour 
 Gestational age of 37+0 to 41+6 
 Singleton gestation 
 Fetal cephalic presentation  
 Confirmed delayed labour  
 Ruptured membrane 
* describe a pregnant woman who has no identified risk factors for 
herself or her baby and who otherwise appears healthy (5) 
The definitions used for the active phase of labour and delayed labour are 
shown in Figure 4. 
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Figure 4. Definitions of active phase of labour and delayed labour 
progress.* Papers III-IV 
 
A flow diagram in Figure 5 is showing the selection procedure. Women not 
meeting the inclusion criteria were those with a suspicious or pathological 
CTG, heavy meconium stained amniotic fluid, fever, medical or psychosocial 
history, pregnancy- or labour-related complications, suspected abnormal 
presentation, suspected fetal growth restriction (< -2 standard deviation) 
difficulty understanding written and oral information given in Swedish, age < 
18 years and hypersensitivity to oxytocin therapy. Women with delayed labour 
and fetal head station below the ischial spine in second stage were also 
excluded. Some of the eligible women had already received oxytocin for 
augmentation before confirmed delayed labour and they were not included in 
the study. 
  
Active phase of labour 
 Regular painful contractions  
 An effaced cervix and  
 Cervix dilation of > 3-4 cm 
Delayed labour  
 First stage – based on the partogram alert and action line. A 
three-hour action line defined delayed labour. 
 Second stage – the arrest of the descent of the fetal head for 
one to two hours 
* In accordance with the Swedish national recommendations 2011 (20) 
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Figure 5. Flow diagram Papers III-IV 
 
 
Intervention and data collection 
The intervention consisted of comparing two different doses of synthetic 
oxytocin administered to women with delayed labour progress. The hypothesis 
was that a regimen of high-dose oxytocin compared with a low dose will 
reduce the number of caesarean sections without negative maternal and 
neonatal outcomes. 
 High dose: 33.2 micrograms of oxytocin in 1,000 ml of 
isotonic saline solution. The infusion began with 6.6 mU of 
oxytocin/min (20 ml/h) and could be increased every 20 
minutes by 6.6 mU to a maximum dose of 59.4 mU /minute. 
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 Low dose: 16.6 micrograms of oxytocin in 1,000 ml of 
isotonic saline solution. The infusion began with 3.3 mU of 
oxytocin/minute (20 ml/h) and could be increased every 20 
minutes by 3.3 mU to a maximum dose of 29.7 mU 
oxytocin/minute. This “low dose” is the recommended 
standard dose in Sweden (20). 
General written information about the study was available on the included 
labour wards. Women in the active phase of labour were monitored according 
to current guidelines. If delayed labour was defined, together with an intact 
membrane, amniotomy was conducted. If there was still no progress one hour 
after amniotomy and the criteria for participation were fulfilled, oral and 
written information was given. After providing consent, the women were 
randomly allocated to receive a regimen of either a high or a low dose of 
oxytocin. 
The oxytocin infusion was increased until adequate uterine contractions were 
obtained and the progress of labour was established (i.e. dilation of cervix and 
descent of the fetal head), or the occurrence of a maximum of five contractions 
during 10 minutes. The monitoring of the labour progress included assessing 
maternal and fetal health and followed established and known routines based 
on national and departmental guidelines. 
The progress of labour was documented in each woman’s medical record and 
in a specific check-list protocol. The following variables were assessed at 
every change of infusion rate and once an hour after a therapeutic dose was 
obtained: 
 Actual infusion rate 
 Frequency of contractions in 10 minutes 
 Fetal surveillance (normal/suspicious/pathological cardio-
tocography) 
 Maternal blood pressure (mm Hg) by oxytocin infusion at 180 
ml/h and every hour thereafter 
Moreover, adverse advents (AE) and severe adverse events (SAE) were 
reported and assessed as mild, moderate and severe (according to guidelines 
from the Medical Products Agency) 
During the study period, an external data and safety monitoring board (DSMB) 
consisting of three scientific experts, a statistician, a senior obstetric consultant 
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and a senior nurse midwife, made periodic reviews and interim analyses of 
study-specific data and gave recommendations on the continuation, 
modification or termination of the trial. 
One month after birth, a revised version of the Childbirth Experience 
Questionnaire (CEQ) was sent out to the women who had received 
augmentation with oxytocin, 601 women in the high-dose group and 602 
women in the low-dose group. The questionnaire consisted of 30 items; 25 
related to the CEQ, two items related to support and three items related to 
breastfeeding. The revised CEQ used in this study includes 20 items evaluating 
childbirth experiences and experience of pain related to the dosage of oxytocin. 
The items are divided into three domains: Own capacity (eight items on sense 
of control, personal feelings during childbirth and labour pain), Perceived 
safety (six items on sense of security and memories from childbirth) and 
Participation (six items on information, midwifery care and own possibilities 
to influence the birthing situation) See Table 3. 
In the analyses of the CEQ, most of the items were rated on a four-point Likert 
scale ranging from Totally disagree, Mostly disagree and Mostly agree to 
Totally agree. The visual analogue scale 0-100 (VAS) was used to rate the 
experience of labour pain, sense of security and control. These scores were 
classified as 0-40 = 1, 41-60 = 2, 61-80 = 3 and 81-100 = 4. For the negatively 
worded items and the pain item, the scores were reversed, which gave higher 
scores for a more positive experience. Self-reported experienced labour pain 
was assessed two hours postpartum and one month after birth. The anchors of 
both VAS scales were worded such as: 0 = no pain – 100 = worst possible pain. 
The primary outcomes were the caesarean section rate (Paper III) and the 
childbirth experience measured with the three domains of the CEQ. (Paper IV). 
The secondary outcomes were various maternal and fetal variables regarded as 
important in evaluating the effect of the intervention. In addition, data on 
various aspects of the use of oxytocin were analysed (Paper III) and, for Paper 
IV, self-reported experienced labour pain and mode of delivery were 
additionally revised. 
  
Delayed Labour-risk factors, use of oxytocin and outcomes 
34 
Table 3. The Childbirth Experience Questionnaire (CEQ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2 Statistical analysis 
For the analysis of the data, the Statistical Package for Social Sciences (SPSS) 
version 12 (Paper I); version 16 (Paper II); version 24 (Papers III-IV) were 
used (SPSS, Inc., Chicago, IL, USA). In addition, SAS 9.4 (SAS Institute Inc., 
Cary, NC, USA) was used for Paper III. A p value of < 0.05 was considered 
to denote statistical significance. 
Table 3. Dimensions and items included in childbirth experience 
Own capacity  
Labour and birth went as I had expected 
I felt strong during labour and birth  
I felt capable during labour and birth  
I was tired during labour and birth  
I felt happy during labour and birth  
I felt that I handled the situation well  
As a whole, how painful did you feel childbirth was? (VAS)  
As a whole, how much control did you feel you had during childbirth? 
(VAS) 
Perceived safety  
I felt scared during labour and birth  
My impression of the team´s medical skills made me feel secure 
I have many positive memories from childbirth 
I have many negative memories from childbirth 
Some of my memories from childbirth make me feel depressed  
As a whole, how secure did you feel during childbirth? (VAS) 
Participation 
I wish the staff had listened to me more during labour and birth 
I took part in decisions regarding my care and treatment as much as I 
wanted 
Both my partner and I were treated with warmth and respect 
I received the information I needed during labour and birth 
I would have preferred the midwife to be more present during labour 
and birth 
The midwife conveyed an atmosphere of calm 
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4.2.1 Paper I 
Group comparisons were made between women with and without delayed 
labour. Statistical associations between categorical variables were tested using 
the chi-square test or the two-tailed Fisher’s exact test. The two-sample t-test 
was used to analyse normally distributed continuous variables. To predict risk 
factors for delayed labour, multiple logistic regression using a forward 
stepwise model was applied. Outcome variables were controlled for parity, 
birth weight and epidural analgesia, while unadjusted and adjusted odds ratios 
(OR) were reported together with 95% confidence intervals (CI). Dummy 
variables were created for parity (reference level “multipara”) and EDA 
(reference level “no EDA”). 
4.2.2 Paper II 
Group comparisons were made between women with and without oxytocin 
infusion and between women with and without delayed labour progress. 
Statistical associations between categorical variables were tested using the 
chi-square test or the two-tailed Fisher’s exact test. 
4.2.3 Paper III 
The sample size estimation was based on an assumed decrease in primary 
endpoint CS from 17.5% to 13%, i.e. a reduction of 25%. A total size of 2,090 
women was needed for 80% power at a significance level of p < 0.05. 
An intention-to-treat analysis (ITT) was used with the exception of 56 women 
excluded from the ITT due to incorrect randomisation or withdrawal of 
consent. (Some of the women with incorrect randomisation were detected 
immediately after randomisation and without intervention.) In addition, per-
protocol analyses were performed for main obstetric outcomes. Statistical 
associations between categorical variables were tested using the chi-square test 
or the two-tailed Fisher’s exact test. The Mann-Whitney U-test was used for 
continuous variables. The calculation of differences between groups for the 
confidence interval (CI) in continuous variables was based on bootstrapping. 
For exploratory purposes, an interaction analysis was performed for major 
baseline variables and dose group in relation to the primary outcome variable 
of CS rate. Subgroup analysis were performed for the latent phase. 
4.2.4 Paper IV 
Statistical associations between categorical variables were tested using the chi-
square test or the two-tailed Fisher’s exact test. The Mann-Whitney U-test was 
used for continuous variables. Cronbach’s alpha was used to assess the internal 
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consistency reliability of the CEQ domains. Childbirth experience between 
mode of birth (spontaneous vaginal birth, instrumental vaginal birth and 
caesarean sections) in high- and low-dose groups respectively was compared 
with the Kruskal-Wallis test. Experiences of labour pain changing over time 
were tested using the Wilcoxon signed rank test. 
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5 ETHICAL CONSIDERATIONS 
Both studies (Study 1 and 2) in this thesis were approved by the Regional 
Ethics Board in Gothenburg (Study 1: Papers I-II: Dnr:520-02; Study 2: 
Papers III- IV: Dnr: 090-12) and followed the Helsinki Declaration. In 
addition, Study 2 (Papers III-IV) was approved by National Medical Products 
Agency (Eudra-CTnr: 2012-000356-33) and is registered at ClinicalTrials.gov 
(NCT01587625). 
Papers I-II: No consent from the women was assessed to be necessary in these 
two studies, as data were retrieved from the patient records. The data were 
decoded in connection with the data collection and personal data could not be 
traced without the code key. With respect to the risk of breaches of privacy 
when using patient records in research, two people were responsible for the 
data collection and they worked together. A method was developed for the 
collection of data and data entry. The method was used to minimise the time 
taken for the review of every single patient record. This prevented the reviewer 
reading details irrelevant to the study. 
Papers III-IV: Information about the study was available on the labour ward 
and women received written and oral information when a delayed labour 
progress occurred. Determining the optimal time to ask a woman in labour if 
she wants to participate in a study could be regarded as an ethical dilemma. 
We decided not to ask all the women on admission to the labour ward, but only 
women with confirmed delayed labour were asked to participate. The decision 
was made to avoid involving women with a normal labour progress in the 
study. Consent was obtained from the participating women and they were 
informed that they could withdrew consent at any time without any 
consequences in terms of care during labour and birth. The risks and benefits 
of performing a study comparing high and low doses of oxytocin infusion for 
the augmentation of labour has been assessed. The augmentation of labour with 
synthetic oxytocin can produce a hyperactive uterine contraction pattern with 
a risk of fetal asphyxia. However, when rigorous protocols for oxytocin dosage 
are followed, adverse fetal outcome has not been identified. When oxytocin is 
administered together with a safety protocol, it has the potential to be a safe 
and effective treatment for delayed labour that can minimise CS and increase 
the rate of spontaneous vaginal birth, together with a positive childbirth 
experience. During the study period, the Swedish national recommendations 
for augmentation with oxytocin infusion were strictly followed. In addition, a 
checklist was used to minimise the risks of tachysystole together with 
suspicious or pathological CTG. 
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6 SUMMARY OF THE FINDINGS 
6.1 Paper I 
Dystocia in labour – risk factors, management and outcome 
Of the study population (n=1,480 women), delayed labour was identified in 
21% of all labours. The frequency of delayed labour in nulliparous women and 
multiparous women with no previous vaginal birth (MNPVD) was 33.6% and 
37.5% respectively, compared with 7.6% in other multiparous women. 
Independent risk factors for delayed labour, in addition to nulliparity and 
MNPVD, were gestational age ≥ 42 weeks, epidural analgesia (EDA) both at 
cervical dilation of ≤ 5 cm and at cervical dilation of > 5 cm, birth weight > 
4,000 g and time for amniotomy (Table 4). The induction of labour was not 
associated with a delay in labour. 
 
Table 4. Major independent risk factors associated with delayed labour 
 OR (CI 95%) p-value 
Parity   
   Nullipara 4.5 (2.8-7.1) <0.001 
   Multipara 1(Reference)  
   MNPVD٭ 6.0(2.2-16.2) <0.001 
EDA   
   No EDA 1(Reference)  
   EDA at cervical dilation ≤ 5cm 
   ≤5cm 
4.6 (2.8-7.7) <0.001 
   EDA at cervical dilation >5 cm 
    >5cm 
2.0 (1.3-2.0) 0.003 
Gestational age ≥42 weeks 3.1(1.5-6.3) 0.002 
Birthweight >4000g 2.7 (1.8-4.2) <0.001 
Amniotomy (h)٭٭  1.3 (1.2-1.4) <0.001 
Data presented as OR(odds), 95% CI and p-values. ٭Multiparaty with no previous vaginal 
birth. ٭٭Time given in intervals of 0.5 h, from active phase to amniotomy 
 
Among labours with a birth weight over 4,000 g, 30.6% were affected by 
delayed labour compared with 17.4% of labours with a birth weight of less 
than or equal to 4,000 g. 
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Epidural analgesia (EDA) was given to 41% of the women (57.3% nulliparous 
and 24.4% multiparous) and delayed labour affected more women with EDA 
(33.4%) than women without (12.5%). Women with delayed labour more 
frequently received EDA at cervical dilation of ≤ 5 cm than EDA at cervical 
dilation of > 5 cm (37.3% and 27.7% respectively) 
The frequency of operative deliveries, i.e. instrumental vaginal delivery or CS, 
was high among women with delayed labour Spontaneous vaginal birth 
occurred in 61.4% of women with delayed progress compared with 93.6% in 
women with normal progress and the CS rate was 16.7% compared with 1.7% 
(Table 5). Multiparous women with no previous vaginal birth (MNVPD) gave 
birth spontaneously in 75 %. In addition, outcomes such as postpartum 
haemorrhage of >1,000 ml and third- and fourth-degree lacerations did not 
show any association with delayed labour when controlling for parity, birth 
weight and epidural analgesia. 
Table 5. Delayed labour and mode of delivery 
 Delayed 
labour 
(n=311 
No delayed 
labour 
(n=1.169 
Unadjusted OR 
(CI 95%) 
Adjusted OR 
(CI 95%) 
Spontaneous 
vaginal birth 
191 
(61.4%) 
1.094 (93.6%)   
Instrumental 
vaginal birth 
68 
(21.9%) 
55 
(4.7%) 
5.7 (3.9;8.3) 3.5 (2.3;5.4) 
Caesarean 
section 
52 
(16.7%) 
20 
(1.7%) 
11.5 (6.8;19.7) 6.3 (3.5;11.2) 
 
Neonatal acidemia referred to as an umblical cord arterial pH of < 7.10 and an 
Apgar score of < 7 at five minutes, was similar in women with and without a 
delayed labour. 
6.2 Paper II 
Use and abuse of oxytocin for augmentation of labour 
This subset in Study I (Paper II) comprised nulliparous and multiparous 
women with spontaneous onset of labour. Multiparous women without a 
previous vaginal birth were excluded. Among the 1,263 women, the delayed 
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labour frequency was 19.8%, i.e. 32.7% in nulliparous and 7.4% in multiparous 
women. 
Oxytocin was administered to 55% of the women (72.8% of nulliparous and 
38.1% of multiparous). The majority of the women receiving oxytocin for 
augmentation, 57% of the nulliparous and 82.9% of the multiparous women, 
did not meet the criteria for delayed labour. For women with delayed progress, 
oxytocin augmentation was started both ‘too early’ and ‘too late’ in relation to 
the diagnosis.  
The frequency of operative birth (instrumental vaginal birth and CS) in 
nulliparous women was higher for oxytocin recipients with delayed labour than 
for oxytocin recipients without delayed labour (40.9% versus 13.6%; 
p<0.001). 
In nulliparous women, the frequency of CS in oxytocin recipients with and 
without delayed labour was 17.1% and 2.3% respectively and, in multiparous 
women, 2.4% and 1.5% respectively (Figure 6). The main indication for CS 
was delayed labour (74.5%). CS due to fetal asphyxia occurred in 23.4% and 
for other reasons in 2.1%. 
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Figure 6. An overview of delayed labour, oxytocin use and CS related to 
parity. 
 
The neonatal outcome Apgar score of < 7 at five minutes did not differ between 
the oxytocin group and the non-oxytocin group. 
6.3 Paper III 
High dose versus low dose of oxytocin for augmentation of labour 
The trial was terminated after results from the interim analyses showing 
futility. A total of 1,351 nulliparous women with spontaneous onset of labour 
were randomised and of these 1,295 were analysed on an intention-to-treat 
basis (high-dose oxytocin group n=647; low-dose oxytocin group n=648). The 
mean age of the participating women was 29 years and, in the majority (78%) 
of the women, labour had started with uterine contractions. By the time of 
admission to the labour ward, cervical dilation was on average 3.5 cm and 35% 
of the women had experienced a prolonged latent phase (> 18 hours) before 
entering the active phase of labour. Baseline characteristics related to 
pregnancy and labour were similar in the two oxytocin groups. 
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There was no difference between the high-dose and the low-dose group with 
respect to the frequency of CS, 80 of 647 women (12.4%) versus 80 of 648 
women (12.3%). The frequency of instrumental and spontaneous vaginal birth 
was also found to be similar in the two oxytocin groups. The main indication 
for instrumental vaginal birth was fetal distress (43.8%) in the high-dose group 
and failure to progress (58.8%) in the low-dose group.  Labour duration was 
23 minutes shorter for women with a high-dose regimen.  
No differences between the oxytocin groups were found in relation to 
secondary maternal outcomes, such as fever during labour of > 38.0 degrees, 
postpartum haemorrhage of > 500 and > 1,000 ml, manual removal of the 
placenta, anal sphincter injury (grade 3 or 4), or neonatal outcomes, such as 
intrapartum thick meconium, FHR abnormality, perinatal mortality, 5 minutes 
Apgar score < 4 or < 7, metabolic acidosis (pH<7.05 and base excess ≥ -12 or 
pH <7.0), admission to the NICU and stay in the NICU (days). The results of 
the per-protocol analysis comprising 1,130 women did not differ from the ITT 
analyses. 
Women in the high-dose group received a larger amount of oxytocin compared 
with women in the low-dose group and the maximum dose per minute was 
higher. In addition, more women with a high-dose regimen suffered from 
events of uterine tachysystole. Mode of birth, labour duration and oxytocin 
given by treatment arm are shown in Table 6. 
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Table 6. Mode of birth, labour duration and oxytocin given by treatment arm. 
 High dose of 
oxytocin 
(n=647) 
Low dose of 
oxytocin 
(n=648) 
p-
value 
Difference 
between groups 
Mean (95% CI) 
Primary outcome     
Caesarean section 80 (12.4%) 80 (12.3%) 1.00 0.0 (-3.7;3.8) 
Secondary outcomes     
Spontaneous vaginal birth 471 (72.8%) 471 (72.7%) 1.00 0.1 (-4.9;5.1) 
Instrumental vaginal birth 96 (14.8%) 97 (15.0%) 1.00 -0.1 (-4.2;3.9) 
Duration of labour (min) 744 (209) 732 
(595; 873) 
n=645 
768 (196) 759 
(635; 891) 
n=648 
0.021 -23.4 (-45.3; -1.5) 
     
Total dose of oxytocin (µg) 7.98 (8.29).5.35 
(2.70; 10.10) 
n=646 
5.74 (5.54) 4.00 
(2.00; 7.30) 
n=639 
<.0001 2.25 (1.48;3.02) 
Maximum dose of oxytocin per min 
(µg/min) 
0.049 (0.034) 
0.044 (0.022; 
0.066) 
n=634 
0.031 (0.019) 
0.028 (0.017; 
0.042) 
n=615 
<.0001 0.018 (0.015; 0.021) 
Total duration of oxytocin infusion 
(hours) 
4.78 (3.07) 4.00 
(2.50; 6.60) 
n=646 
5.17 (3.16) 
4.50 (2.80; 7.00) 
n=641 
0.013 -0.39 (-0.73;- 0.05) 
Uterine tachysystole (number of 
women with any episode) 
279 (43.2%) 
n=641 
215 (33.5%) 
n=641 
0.0005 
 
9.6 (4.2;15.1) 
Oxytocin stopped or reduced *  136 (21.1%) 
n=646 
102 (15.9%) 
n=641 
0.021 5.1 (0.8;9.5) 
For categorical variables, n (%) is presented. For continuous variables, the mean. (SD)/median. (Q1; Q3)/n 
= is presented   
*Oxytocin stopped or reduced due to tachysystole with suspicious or pathological fetal heart rate pattern (number 
of women with any episode)    
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A significant interaction was seen between the latent phase and the two 
oxytocin groups (p=0.028). Further subgroup analyses of women with a 
prolonged latent phase (> 18 h) and women with a latent phase of ≤ 18 h did 
not reveal any differences in CS rate between the study groups. No 
interaction effects could be seen between the other baseline characteristics, 
such as maternal age (p=0.052) and stage of labour (first and second) (p=0.49).  
The occurrence of adverse events (AE) was similar in the two dosage groups. 
Thirty-one (4.8%) were reported in the high-dose group and 39 (6.0%) in the 
low-dose group. The majority of these reported adverse events were nausea 
and vomiting. Three cases in the high-dose group and one in the low-dose 
group experienced a severe adverse event (SAE). None of the SAEs were 
regarded as drug related. one woman with an SAE in the high-dose group did 
not receive study treatment. In the low-dose group, one perinatal death 
occurred in a child with severe hypoxic encephalopathy. It was regarded as not 
being related to the study drug and one woman with a SAE in the high-dose 
group did not receive treatment.  
6.4 Paper IV 
Women’s childbirth experiences in relation to dosage of oxytocin for 
augmentation of labour 
The questionnaire was sent out to 1,203 women one month after birth and, of 
these, 1,008 (83.8% response rate) women answered and returned the 
questionnaire, 497 (82.7%) in the high-dose group and 511 (84.9%) in the low-
dose group. Cronbach’s alpha coefficients for the three domains were Own 
capacity: a=0.80, Perceived safety: a =0.81 and Participation: a=0.83. 
The characteristics of the study group did not differ between the high-dose 
group and the low-dose group, except for oxytocin administration and labour 
duration. Women in the high-dose group were given a larger total amount of 
oxytocin (p<0.001) – the maximum dose of oxytocin per minute was higher 
(p=0.001), and labour duration was 29 minutes shorter (p= 0.018) compared 
with women in the low-dose group.  
There were no significant differences in childbirth experience, measured in the 
three domains, between the high-dose group and low-dose group (Own 
capacity (p= 0.99), Perceived safety (p = 0.43), Participation (p = 0.55) (Table 
7). 
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Table 7. The three domains of childbirth experience (CEQ) and comparisons 
between dose of groups. 
 High dose of 
oxytocin 
(n = 497) 
Low dose of 
oxytocin 
(n = 511) 
p-value٭ 
Own capacity 2.43 (0.55) 2.46 (0.56) 0.99 
Perceived safety 3.03 (0.72) 3.06 (0.71) 0.43 
Participation 3.56 (0.54) 3.58 (0,50) 0.55 
The data are given as the mean (SD). Min value = 1, max value = 4. ٭ Mann-Whitney U-test 
 
When comparing childbirth experiences with mode of birth (spontaneous 
vaginal birth, instrumental vaginal birth and caesarean section), a higher mean 
score in all three domains was seen for women with a spontaneous vaginal 
birth compared with women with an instrumental vaginal birth and caesarean 
section (p<0.001). 
Epidural analgesia was used by 870 (86.3%) of the women and was 
administered both before and after delayed labour was defined and 
augmentation with oxytocin had started. None of the intrapartum analgesics 
used during labour differed between the oxytocin groups. Nor did reported 
labour pain scored two hours postpartum (mean score 65.9 in high-
dose(n=329) versus 67.5 in low-dose (n=346); p=0.67) and one month after 
birth (mean score 73.4 in high-dose (n=497) versus 71.7 in low dose(n=511); 
p=0.25) differ between the two dosage group. Labour pain scored postpartum 
was compared with labour pain scored one month after birth in 565 women 
who reported labour pain on both occasions. Experienced labour pain was 
scored significantly higher one month after birth compared with two hours 
postpartum (mean score 73.1 versus mean score 66.9; p=0.012). Different pain 
reliefs used during labour are shown in Table 8. 
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Table 8. Pain reliefs used during labour (%)* 
*Morphine and Ketogan were given in the latent phase 
TENS-Transcutaneous nerve stimulation,  
PCB-Paracervical nerve block 
 
  
93,7
86,3
30,1
22,9 18,9
8,9 6,4
2,1
0
10
20
30
40
50
60
70
80
90
100
Delayed Labour-risk factors, use of oxytocin and outcomes 
48 
 
Lotta Selin 
49 
7 METHODOLOGICAL CONSIDERATIONS 
The study design used in this thesis consisted of both a retrospective 
observational study (Study 1) and a randomised, controlled trial (RCT) (Study 
2). The first step (Study 1) was based on an exploratory, descriptive approach 
to collect more knowledge of delayed labour and the use of oxytocin in relation 
to delayed progress. Based on the findings from this first study and from the 
literature a gap of knowledge regarding oxytocin use was identified. We 
formulated a hypothesis of oxytocin use which could be tested in an 
intervention study with an RCT design (Study 2). 
The research quality of observational studies and RCTs is evaluated in terms 
of both internal and external validity. Internal validity refers to the strength of 
the inferences from the study and to a lack of systematic error. The key 
question when assessing internal validity is whether an observed change can 
be assumed to be associated with the exposure and not with other possible 
factors. External validity refers to the ability to generalise study results to a 
wider population of interest, i.e. for other persons in other places and at other 
times (126). 
The observational study design 
In observational research, the direct observation of individuals in their natural 
setting is performed and inferences are drawn about the effect of an “exposure” 
or intervention on subjects through the observation without manipulation (e.g. 
through randomisation) by the investigator (126). To select the study sample 
in observational studies, a random sampling system is used, which means that 
each person in a defined population has the same chance of being selected. 
Random sampling is unable to protect from extraneous variables that may 
confound the result in a study (127). For this reason, the main limitation of an 
observational study is the existence of alternative explanations for study results 
due to confounding by both factors within the study material and factors not 
observed in the study. 
Furthermore, the direccion of causality is not clear in observational studies. 
For example, an association between epidural analgesia and delayed labour can 
have different explanations, such as whether epidural analgesia causes delayed 
labour or whether delayed labour is painful and requires pain relief. In addition, 
associations found in exploratory and descriptive research are weaker than in 
hypothesis-testing research, but they can open the door to new research 
questions. 
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In our retrospective observational study (Study 1), the sample was obtained by 
random sampling and via a computer random number generator in Excel. All 
the data were collected from the women’s electronic birth records®. The 
variable of interest was “delayed labour”, but, at the time of the study, our 
labour ward did not have a clear definition of delayed labour and all women 
receiving oxytocin for augmentation also received a diagnosis of delayed 
labour. In the study, the definition of delayed labour was based on the 
partogram two-hour alert line and in accordance with the Swedish Society of 
Obstetrics and Gynaecology, Normal labour practice (1). The definition of 
delayed labour was assessed by two midwives retrospectively and together 
with the collection of data.  
The RCT study design 
RCTs are perceived as the best standard research design for evaluating the 
effectiveness of treatments and interventions, as they have good internal 
validity and minimise confounding. Through random allocation, the study 
participants are allocated to the groups in such a way that each one has an equal 
chance of being allocated to either group. With random allocation, the risk of 
extraneous variables confounding the result is minimal and the probability that 
any differences observed between the groups is dependent on the 
interventional variable increases (127). In addition, RCT studies can yield 
causal relationships through the controlled design. However, RCT studies are 
not always possible to conduct in medical research for various reasons, not 
least for ethical reasons.  
The RCT (Study 2) in this thesis had a multicentre design, was pre-registered 
and a statistical analysis plan was formulated before closing the data file and 
starting the analysis process. In addition, the study was conducted in 
accordance with the CONSORT guidelines (128). An intention-to-treat 
approach was used for the analysis to strengthen the internal validity. The study 
protocol was approved by the Swedish National Medical Products Agency.  
Threats to the internal and external validity 
Different threats to the internal and external validity can be seen in 
observational studies and, as mentioned above, confounding is a threat to 
internal validity. Methods to control confounding include restriction, 
stratification and multivariate techniques (129). In Study 1 (Paper I), no 
restriction was made, as the study design had an exploratory and descriptive 
design comprising the population on the delivery ward (nulli- and multi-parous 
women with both spontaneous and induced labour). For Paper II, a restriction 
was made with the aim of analysing women with spontaneous onset of labour. 
Multiparous women with no previous vaginal birth and women with induced 
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labour were excluded. Finally, in the RCT, Study 2 (Papers III and IV), only 
nulliparous women with spontaneous onset of labour were included. A logistic 
regression method was used in Study 1 (Paper I). Adjustments were made 
using the variables known to or suspected of having a relationship with the 
dependent variable. However, we were only able to control for confounders in 
the variables obtained from the birth records and included in the analyses. 
Unfortunately we did not have information about parameters such as women’s 
BMI, continuous support during labour, fear of childbirth etc. to include in the 
analyses.  
When selection bias occurs, the obtained sample is not representative of the 
defined population of interest and is a threat to validity. When using a central 
randomisation system, selection bias is considered to be a low risk. The 
randomisation process in both studies was performed via a computer random 
number generator. There might have been a threat to internal validity due to 
selection bias in Study 2 ( Papers III and  IV). A large number (n=922) of 
eligible women were not included in the study because they had not been 
informed and asked for consent to participate by the responsible midwife. The 
midwives were asked to give reasons for not including eligible women in the 
study and, in most of the cases, the reasons were that they had simple forgotten 
to ask the woman to participate or because of a heavy workload. In a few cases, 
the women were “too afraid” or had “too much pain” to be disturbed with 
questions about participating in a study. In most of the cases, no reason was 
given. 
In terms of women’s childbirth experiences evaluated in the CEQ 
questionnaire (Paper IV), 16% of the women did not answer the questionnaire 
sent out one month after birth. No analyses were made of non-responders, 
which could have created some selection biasis. We do not know whether this 
group differs from the one answering the questionnaire and the degree to which 
this could have influenced the childbirth experiences. However, a response rate 
of 80% is regarded as strengthening the external validity. 
When it came to external validity, only Swedish-speaking women were asked 
to participate in the RCT, which might be a threat to the external validity for 
geographical areas with a population with many non-Swedish-speaking 
women. On the other hand, the external validity of the study was strengthened 
by the multicentre approach and the fact that the trial was conducted in 
different regions of Sweden, which increased the opportunity to generalise. In 
study I external validity was threatened by that the research was limited to one 
hospital 
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Blinding is necessary to control bias in clinical trials. Through blinding, threats 
to internal validity and construct validity are minimised (126). The intervention 
in the RCT was double blinded, i.e. neither the women receiving the treatment 
nor the responsible midwife knew which dosage group the women had been 
allocated to. The randomisation process was performed via a computer random 
number generator. The randomisation was performed and the intervention was 
prepared by another person on another ward, but, in spite of this, we are unable 
to guarantee the security of full blindness. The most ideal solution would have 
been to have used special vials with the study drug produced exclusively for 
the trial, but we did not have the financial resources for this option. 
Statistical conclusion validity refers to whether the research design together 
with the statistical measurements is able to detect a true relationship (130). In 
our retrospective observational study, associations between the explanatory 
and dependent variables must be interpreted with caution, as associations in 
observational studies are weaker than those in an experimental study and 
causality cannot be proved.  
When designing the RCT, we used the data from Study 1 (Paper II) to calculate 
the sample size needed to detect a true difference between the dosage groups 
for our primary endpoint of CS. The results from Study 1 (Paper II) had shown 
a CS rate of 17.2% in nulliparous women with spontaneous onset of labour and 
with confirmed delayed labour. Other Danish study has reported similar result 
for the CS rate in the same defined group (31). The sample size calculation for 
the RCT was based on this finding and the estimated decrease in the primary 
endpoint, CS rate, from 17.5% to 13%, i.e. a reduction of 25%, which also was 
considered clinically relevant. To achieve this, it was thought that 1,045 
women would be needed in each group, resulting in a total of 2,090 women. 
The result of the RCT, however, showed a CS rate, in both groups (12.4% vs 
12.3%), (Paper III) that was less than that estimated in the power calculation, 
something that might depend on much stricter inclusion criteria than in our 
retrospective observational study as exclusion of labours with meconium 
stained amniotic fluid and suspicious or pathological CTG. 
After the interim analysis and recommendations from the Data Monitoring 
Safety Board, the RCT was ended before we had reached full inclusion. The 
reason was the extremely small numerical difference in the CS rate between 
the two study groups and, with the assumption that even with a completed 
study, with the inclusion of 2,090 women, it would be unlikely to achieve a 
statistically significant difference in CS rate between the two dosage groups.  
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Information bias can occur when information is either measured, or collected 
inaccurately. In the retrospective observational study, data were collected by 
the same two midwives and, on some rare occasions, by a third midwife. All 
three were trained in scrutinising the women’s labour records, definitions of 
delayed labour and the entry of data.  
In the RCT, all manual data were double checked. Missing values from the 
Obstetrix® database were checked in the women’s pregnancy or labour records 
and, when possible, entered in the CRF. For instance, the women’s last weight 
was seldom filled in from the pregnancy record to the labour record. This was 
found at all participating centres and assessed by the research team as 
important to collect in order to avoid any information bias.  
Regarding validity in the Childbirth Experience Questionnaire (CEQ), the first 
version has shown good measurement qualities and has been validated in 
Sweden (131),United Kingdom (132) and in Spain(133). The questionnaire has 
previously been used in women with delayed labour (102). The CEQ used in 
the RCT ),(Paper IV) is a revised version where validation has been performed 
for the two subscales Own capacity and Perceived safety, but not yet been 
completed for the subscale Participation. 
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8 DISCUSSION 
The overall aim of this thesis was to investigate risk factors, the use of oxytocin 
and outcomes in relation to a delayed labour progress. This was investigated 
in two studies, one retrospective observational study and one RCT, resulting 
in four papers: Paper I and II for the first study, and Paper III and IV for the 
second study. 
The result showed that nulliparous women ran an increased risk of delayed 
labour and operative birth (instrumental vaginal birth and CS). Multiparity 
without previous vaginal birth was also a risk factor for delayed labour and CS 
(Paper I). Oxytocin augmentation was used in an incorrect manner, both in 
excessive doses and by administration “too early or too late”(Paper II). When 
comparing a high dose with a low dose for the augmentation of delayed labour, 
neither dose was shown to be superior in outcomes as intrapartum CS, 
childbirth experiences or other secondary outcomes, despite a moderately 
shorter labour duration for the women in the high-dose group. More events of 
tachysystole and signs of fetal distress occurred with a high-dose regimen 
(Paper III-IV). As a result, a low-dose oxytocin regimen is recommended for 
the treatment of delayed labour. 
Risk factors for delayed labour and outcomes 
In the retrospective observational study multiparity without a previous vaginal 
birth was found to be the main independent risk factor for delayed labour 
(Paper I). Our results correspond with the results of a recent Swedish 
population cohort study investigating the risk of recurrence and operative birth 
following labour, using data from the Swedish Medical Birth Register (134). 
The population cohort study result showed an increase in the risk of a 
recurrence of delayed labour in women with a previous CS. 
In our study, nulliparity was a strong risk factor and the frequency of delayed 
labour in nulliparous women was 32.7%, i.e. almost one in every three women 
expecting their first child was considered to require intervention to augment 
labour progress. (Paper II). The fact that nulliparous women run an increased 
risk of delayed progress is well known from other studies reporting an 
incidence of between 35.6-44% (29-31). However, according to Zhang et al., 
there is a need for a re-evaluation of contemporary practice in assessing labour 
progress for nulliparous women, due to a possible overly stringent definition 
of delayed labour. In current obstetric care, labour progression in the active 
phase takes longer than was considered when the Friedman curve was shaped. 
This may be due to changes in both population and current obstetric care. For 
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instance, women are older and heavier and fetal birth weight has increased, 
together with an increase in the use of medical and technological interventions. 
Allowing labours to take longer before cervix dilation of 6 cm may reduce the 
rate of interventions like amniotomy and oxytocin use as well as the CS rate 
(11). 
Factors affecting labour progress shown in Paper 1, such as gestational age 
and birth weight, are known from earlier studies (31-33). At the time point 
when the data for the retrospective observational study were collected (Paper 
I), management on the labour ward regarding amniotomy did not follow a strict 
protocol and was often performed electively as a routine, following a decision 
by the responsible midwife or obstetrician. Our study (Paper I) showed an 
association between the time for amniotomy and delayed labour and we found 
that amniotomy was performed almost one hour later in the group of women 
with delayed labour. Other studies have reported conflicting results. Whether 
or not routine amniotomy is beneficial for women when there is no specific 
indication has been questioned (135) and it is not recommended by the WHO 
(28). 
Latent phase and early admission to the labour ward are known risk factors 
for delayed progress, but these factors were not evaluated in our observational 
study. Despite this, it may be worth mentioning that the descriptive data of the 
women participating in our RCT showed that 35% of these women, 
subsequently diagnosed with delayed labour, had experienced a prolonged 
latent phase (> 18 hours) and were on average admitted in early labour. By the 
time of admission to the labour ward, cervical dilation was 3.5 cm on average 
(Paper III). 
Whether there is a cause-and-effect relationship between an epidural analgesia 
and delayed labour is a controversial issue. An association between longer 
labours and epidural analgesia has been reported in various studies (45), but 
the impact on labour duration in the first stage of labour is still unclear (53). In 
our observational study, after controlling for confounders, both early and late 
epidural analgesia were risk factors for delayed progress, with an increased 
risk when the analgesia was initiated at an early stage (by cervical dilation ≤ 5 
cm) (Paper I). Compared with earlier randomised studies, the early or late 
initiation of epidural analgesia for labour had the same effect on labour 
duration in the second stage of labour (53).  
Delayed labour and an increased risk of operative birth, especially in 
nulliparous women, have been reported previously in the background. We 
found a strong relationship between delayed labour and operative births. Just 
Lotta Selin 
57 
over half (61.4%) the women in the group with delayed labour succeeded in 
having a spontaneous vaginal birth, compared with 93.6% of women without 
delayed labour(Paper I). The incidence of operative deliveries in nulliparous 
women with delayed labour was 40.9% (23.8% instrumental vaginal birth and 
17.1% CS), despite oxytocin treatment (Paper II).  
For multiparous women without a previous vaginal birth, the CS rate was 
25.0% (Paper I). This can be compared with the Swedish cohort study where 
delayed labour and CS in the first labour were associated with instrumental 
vaginal birth and CS in second labour (134). 
Delayed labour and oxytocin use 
Research on different regimens with oxytocin for improving labour outcome 
has been performed without recording a successful decrease in the CS rate in 
nulliparous women with spontaneous onset of labour. In trials of early or 
delayed oxytocin augmentation, when oxytocin has been used as a single agent, 
no differences have been found in obstetric and neonatal outcomes, apart from 
a reduction in labour duration.  
When comparing a high-dose regimen with a low-dose regimen in the 
treatment of delayed progress in nulliparous women, no difference in the CS 
rate was found between the two oxytocin groups (Paper III). Our RCT study 
was unable to confirm the indication in two systematic reviews of a reduced 
CS rate with a high-dose regimen (103, 105). Furthermore, the mean labour 
duration was 23 minutes shorter with a high-dose regimen of oxytocin 
compared with a low dose. Labour duration has been shown to have an impact 
on women’s childbirth experiences and labours lasting many hours can affect 
the childbirth experience negatively (29, 60). When the optimal dosage is 
discussed, this must be weighed up against the need for increased surveillance 
and control with a high-dose regimen due to the risk of overstimulation. 
Oxytocin administration has been associated with adverse neonatal outcomes, 
usually due to a hyperactive uterine contraction pattern caused by 
overstimulation and described in the background (68, 107-110). In our 
observational study, we did not find a higher frequency of a 5-minutes Apgar 
score < 7. When comparing the use of a high versus a low dose to augment 
labour in the RCT (Paper III), no significant differences in 5-minutes Apgar 
score < 4 or 7 or symptoms of acidosis were found between the two oxytocin 
groups, despite an increased frequency of pathological CTG in the high-dose 
group. This demonstrates the awareness of the midwives and obstetricians to 
reduce or stop the oxytocin infusion when tachysystole occurred. One 
contributory factor in the vigilance relating to CTG changes might have been 
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the use of a modified checklist-based protocol during the study period; a 
protocol recommended by Clarc et al. with the aim of assessing uterine and 
fetal responses to oxytocin augmentation (107). According to Clarc et al., the 
use of checklist-based protocols may be one way of optimising the safety of 
oxytocin application (107, 136). 
Oxytocin use in normal labour 
One of the specific aims in this thesis was to investigate the use of oxytocin 
for augmentation and its relationship with labour progress and outcome (Paper 
II). The decision to augment labour with oxytocin was made by the attending 
midwife or obstetrician, either individually or together. We found that 72.8% 
of the nulliparous women and 38.1% of the multiparous women received 
oxytocin during labour and 57.0% of nulliparous and 82.9% of multiparous 
women received augmentation without an indication of delayed labour (Paper 
II). These data derive from 2000/2001, but other studies both later and more 
recently have reported similar results, with the large-scale overuse of oxytocin 
(90, 136-139)oxytocin, In its annual report for 2016, the Swedish Pregnancy 
Registry indicates that there is a large variation in oxytocin use between the 
different Swedish labour wards. The oxytocin use for augmentation in 
nulliparous women with a spontaneous onset of labour and regarded as low 
risk varied between 38.2% and 88.7% (92). 
The issues that are necessary to reflect on are as follows: Why are women, 
where the majority of them have uncomplicated pregnancies and normal 
labour, augmented with oxytocin and what can this mean for these women? 
In a recent Swedish interview study by Ekelin et al. (140), midwives’ views 
and experiences of labour augmentation in the context of normal labour were 
examined. Despite awareness of intervening in a normal labour progress and 
of the possible consequences of medical interventions, midwives in the study 
felt forced to accelerate labour for different reasons. 
A heavy workload, no free labour rooms and the midwife’s own impatience 
were some of the reasons for speeding up labour. Midwives said they were 
influenced by the views of their colleagues and newly qualified midwives were 
especially influenced by older colleagues’ opinions. If the women had received 
epidural analgesia or labour progress had simply paused, these were seen as 
permissible situations to start augmentation with the aim of preventing delayed 
labour. Preventing delayed progress was regarded as an act of kindness to the 
women (140). In an earlier interview study by Blixt et al., the midwives 
mentioned similar reasons for accelerating oxytocin augmentation; they 
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included decisions by the obstetricians, the opinions of colleagues or a need 
for a labour room (141). 
In neither of the interviews did the midwives appear to reflect on their decision 
to intervene and the impact on women’s feelings of control and confidence in 
their own strength and ability to give birth (140, 141). When medical or 
technological interventions during labour and birth are seen from a 
psychological perspective, intervening can pose a risk that midwives or other 
caregivers who are perceived to be more knowledgeable take over and 
undermine the woman’s confidence in her own body (142). 
In our observational study (Papers I –II), we did not have any information 
about the indication for oxytocin augmentation. The clinical practice on the 
labour ward at the time of data collection was to use a partogram without an 
action line and the alert line was very rarely filled in. Decisions to augment 
labour were based on observational skill and both the overuse of oxytocin in 
women without delayed labour and the fact that oxytocin was given both “too 
early” and too late” could be seen. The partogram with its alert and action lines 
has been the subject of of discussion about whether its use is beneficial or 
results in unnecessary interventions (22, 23). According to our results, the use 
of a partogram without the action line did not prevent the augmentation of 
labour in women with normal labour progress. A German study found that the 
timing of interventions during labour were similar, when a partogram without 
action lines was used.(139) To conclude, a partogram with an action line could 
be a useful tool for both midwives and obstetricians to remind them of normal 
progress; both for oneself and when pressure is coming from other caregivers 
to intervene in normal labour with the aim of accelerating progress.  
In 2008, 62% of the Swedish labour wards did not have criteria for diagnosing 
delayed labour and, in 31% of the labour wards, there was no policy regarding 
the management of delayed labour (143). The implementation of guidelines is 
important (1, 91), but this may not be sufficient as a single tool when routines 
have to be changed (144). In 2011, new national guidelines were introduced 
on Swedish labour wards with recommendations for oxytocin use for the 
augmentation of labour (20). Five years later, data from the Swedish Pregnancy 
Registry indicated the continued high overuse of oxytocin in normal labour 
(92). 
At the NU Hospital Group, where the observational study was conducted in 
2001-2002, the frequency of oxytocin use in nulliparous women with 
spontaneous onset of labour was 72.8% (Paper II) and it decreased to 45.9% 
in 2016 (92). One explanation for the change in routines regarding oxytocin 
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management could be the intensive work that has been done to promote normal 
birth in clinical practice with the emphasis on delayed labour and oxytocin use. 
This action was started after the presentation of the study results. Moreover, in 
2010, a systematic quality development project was set up with the aim of 
strengthening normal childbirth, where oxytocin use was one part (145) 
Similar results were obtained in two Scandinavian hospitals where the 
incidence of oxytocin use decreased significantly after introducing a protocol 
for the definition of delayed labour and for oxytocin use together with 
organised audits for all staff (144, 146). 
According to the WHO, unnecessary clinical intervention in normal labour is 
a threat to women’s autonomy and may negatively impact their childbirth 
experience (28). Nystedt et al. found that women without delayed labour but 
with oxytocin perceived their progress of labour as slow, despite normal 
progress (29). 
Childbirth experience  
There is little research regarding the association between different doses of 
oxytocin and childbirth experience. In our RCT, no difference was found in 
women’s childbirth experience between a high-dose regimen of oxytocin 
compared with a low-dose regimen (Paper IV). Two previous studies have 
reported similar results (96, 147). In one of the studies, no differences were 
found in women’s satisfaction with labour when a high dose of oxytocin 
together with early intervention was compared with a low dose of oxytocin and 
with a more expectant intervention.(96) In the pilot study by Kenyon et al., 
women’s perception of support and control did not differ between a high and 
a low dose of oxytocin, when oxytocin augmentation was investigated as a 
single agent (147). 
Labour and birth are regarded as a multidimensional experience, including 
intense physical, emotional, psychological, cultural and spiritual elements, all 
of which contribute to the childbirth experience (148). Most instruments used 
for assessing women’s childbirth experiences relate to single aspects of birth 
experience (131). The Childbirth experiences questionnaire (CEQ) used in the 
RCT has the ability to measure different dimensions of childbirth experience 
(131). By using the CEQ, it was possible to assess three major dimensions of 
childbirth experience, namely Own capacity, Perceived safety and 
Participation in relation to oxytocin dosage. We did not find any difference in 
childbirth experience in any of the three domains measured by the CEQ 
between the two groups of women receiving either a high dose of oxytocin or 
a low dose. When comparing the three domains, the lowest mean score was 
found for Own capacity, containing items regarding sense of control, personal 
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feelings during labour and experienced labour pain (Paper IV). This may 
reflect a situation in which control over labour and in some cases also birth is 
no longer in the woman’s hands. Previous studies have reported that it is 
important for women to be in control of their birthing process (124, 125). In 
addition, it is a well-known fact that women with delayed labour progress and 
an operative birth are more likely to have a negative childbirth experience than 
women with normal progress (61, 114) Women who participated in our RCT 
and underwent an emergency CS or instrumental vaginal birth gave their 
experience of childbirth lower scores than women with a spontaneous vaginal 
birth in all three domains and in both dosage groups (Paper IV). Women with 
delayed labour need extended support during labour and this is an important 
factor to consider when planning care on the labour ward (60, 123).  
Pain relief during labour 
Many women experience severe pain in labour. Delayed labour and worse than 
expected experienced labour pain have been reported to be two of the main 
factors influencing the childbirth experience negatively (60). Strategies for 
helping women to cope with labour pain can include the use of multiple non-
pharmacological and pharmacological techniques, which can be used 
sequentially or in combination. Some non-pharmacological methods appear to 
be more beneficial in helping women to cope with labour pain than in relieving 
the pain and, on the other hand, pharmacological methods mitigate pain, but 
they may not relieve anxiety or suffering (135). According to ACOG 2006, “In 
the absence of a medical contraindication, maternal request is a sufficient 
medical indication for pain relief during labour and birth” (149). The choice of 
technique, agent and dose should be based on the woman’s preference, her 
medical status and if there are any contraindications (149). 
The majority of the women in our RCT used epidural analgesia and entonox 
as pain relief during labour. The frequency of epidural analgesia use was as 
high as 85% in both oxytocin groups (Papers III and IV). Non-
pharmacological pain relief was used to a moderate to low degree.  
When comparing our finding of epidural analgesia use with data from the 
Swedish Pregnancy Register from 2016, there was a large variation in the use 
of epidural analgesia between Swedish hospitals and the use in nulliparous 
women with a spontaneous vaginal birth varied between 23.2% and 67.5% 
(92). It seems reasonable to assume that the decision on which pain relief to 
use by women in labour is more a decision for the caregivers based on local 
routines and labour ward culture than the woman’s preference. The choice of 
pain relief ought to be based on the woman’s request and she ought to be 
informed and offered both pharmacological and non-pharmacological 
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management techniques and, in addition, receive information that epidural 
analgesia might have an effect on the duration of labour. Despite the high use 
of pharmacological management during labour, women report greater 
experienced pain one month after birth than two hours post-partum (Paper IV). 
When it comes to the approaches to limit interventions during labour and birth, 
ACOG recommend the use of non-pharmacological management techniques 
in the latent phase (135). We do not have any information on the extent to 
which this was used in our study (Papers III and IV), but more than one fifth 
of the women used parenteral or oral opioids in the latent phase. Evidence from 
a recent Cochrane review from 2018 suggests that parenteral opioids might 
provide some pain relief in labour, but, at the same time, they are associated 
with drowsiness, nausea and vomiting in women. In addition, the effects on the 
newborn are unclear (150). 
Care during labour 
This thesis has been conducted within the field of health-care sciences, where 
the meaning of care is to support and strengthen health processes (151). 
According to a Swedish state-of-the-art document (1), the aim of care in 
normal birth is “to achieve a healthy mother and child with the least possible 
level of intervention that is compatible with safety. The approach implies that 
in normal birth there should be a valid reason to interfere with the natural 
process”. Most women want a physiological labour and birth and to have a 
sense of personal achievement and control through involvement in decision-
making, even when medical interventions are needed or wanted (5). 
Supporting the normal physiological processes of labour and birth, even in the 
event of complications that require medical attention, can increase best 
outcomes for the mother and infant (3). 
When care is discussed from the professional’s perspective, there is a risk that 
the patient will “be lost”. As a result, when this perspective is used in health-
care sciences, it is important to highlight the fact that the purpose is to improve 
care for patients and contribute to a caring culture (151). In current obstetric 
care, midwives and obstetricians are the central caregivers for a woman giving 
birth (152). In Sweden, midwives are responsible for normal labour and birth. 
If there is a pregnancy with risk factors or with complicated labour and birth, 
the midwives and obstetricians work together in the surveillance of woman and 
child. According to the Swedish Description of Competence for Registered 
Midwives, the midwife has the competence independently to handle a normal 
pregnancy, childbirth and postnatal period, together with the competence to 
identify and assess when a situation deviates from normal (153). In the 
philosophy and model of midwifery care, pregnancy and childbearing are seen 
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as usually normal physiological processes. According to the International 
Confederation of Midwives (ICM) model of midwifery care, midwives are 
responsible for promoting and protecting women’s and newborns’ health and 
rights and for promoting and advocating non-intervention in normal childbirth 
(154). 
This can be a challenge when most births today occur in hospitals where a more 
biomedical view of childbirth dominates and labour is seen as a critical and 
medical event, and is regarded as normal in retrospect (155, 156). This was 
reflected on in the study by Ekelin et al. where midwives expressed their 
awareness of protecting normal birth but argued that the high-tech hospital 
environment where birth takes place results in a lack of confidence in the 
process of normal birth (140). Professional skills, such as intuition, expertise 
and empathy, in a hectic, busy clinical practice can be difficult to hear (157). 
Sandvik states that the modern midwife stands with both feet in midwifery care 
that originates from traditional female practice and modern biomedical 
discipline. The main challenge is relating to these two concepts (155). 
The findings in Paper III regarding the use and misuse of oxytocin are discussed on 
the basis of the midwifery model of care by Kennedy, where “watchful 
expectancy” is described as “the art of doing nothing well” (158). This means 
ensuring that normality continues through vigilant and attentive care, fostering 
the normal processes of labour and birth intervention and using technology 
only when the individual situation requires (158). Knowledge and judgement 
when taking control of and intervening in a physiological process of labour is 
necessary (158). In this model, the midwife is seen as “an instrument” of care. 
Between the woman and the midwife, there is continual interaction between 
“taking control” and “letting go”(156). This perspective challenges midwives’ 
professional skills in midwifery care; recognising birth as a unique, normal 
process and trusting their own knowledge when it comes to whether or not to 
interfere. 
In this thesis, risk factors and outcomes in delayed labour have been 
investigated. Furthermore, expectancy in management versus interventions in 
relation to treatment with oxytocin infusions has been further explored (I-II). 
In addition, maternity care routines relating to oxytocin use for supporting 
normal childbirth in women with delayed progress, together with experiences 
of childbirth and labour pain, have been studied (III-IV). 
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CONCLUSIONS 
 Nulliparous women and multiparous women without 
previous vaginal birth ran an increased risk of delayed labour 
and an adverse labour outcome, such as CS or instrumental 
vaginal birth, compared with women with normal progress.  
 
 Epidural analgesia was a risk factor for delayed labour, with 
an increased risk when administered at an early stage at 
cervical dilation of ≤ 5 cm.  
 
 An incorrect use of oxytocin for augmentation was found. It 
consisted of both inadequate and excessive use and 
administration both too early and too late in relation to a 
delayed labour diagnosis. 
 
 Oxytocin recipients with delayed labour ran an increased risk 
of CS and instrumental vaginal birth compared with oxytocin 
recipients without delayed labour, indicating that the main 
reason for CS was not the oxytocin augmentation but the 
underlying problem of delayed labour. 
 
 No advantages were found for the routine use of a high-dose 
regimen of oxytocin for the augmentation of delayed labour 
when compared with a low-dose regimen. 
 
 The CS rate did not differ between the two dosage groups. 
 More events of tachysystole occurred with a high-dose 
regimen. 
 A larger amount of oxytocin was used with a high-dose 
regimen. 
 Childbirth experiences when evaluated one month after 
birth with the three dimensions of Own capacity, 
Perceived safety and Participation did not differ between 
the two dosage groups. 
 Experienced labour pain evaluated two hours post-partum 
and one month after birth did not differ between the two 
dosage groups. 
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9 FUTURE PERSPECTIVES 
Different regimens for oxytocin administration need to be further 
evaluated 
Research on different management of oxytocin has not been successful in 
improving labour outcomes such as CS rate. Further investigations of dose-
response to oxytocin in specific groups of women, for example women with 
obesity or women with a prolonged latent phase, should be encouraged. In 
addition, evaluate whether discontinuation of oxytocin infusion could affect 
the duration of the active phase of labour, compared with continuation of 
oxytocin until birth, and without adverse maternal or neonatal outcomes.  
Increase women’s access to nonmedical interventions during labor 
Alternative and non-pharmacological interventions, techniques and methods 
related to labour progression and to women’s preferences have not been 
studied sufficiently. There is a need to extend research in these areas and 
include research on both preventing and treating delayed progress, such as 
research regarding techniques for coping with pain.  
Revisit the definition of delayed labour 
Labour progression ought to be re-evaluated according to the partogram and 
the definition of the active phase of labour to adapt it to the current population 
of women and obstetric practice. This would mean, among other thing, 
allowing nulliparous women to progress more slowly before six centimetres of 
dilation. This may prevent interventions and CS in early labour. 
Stop the abuse of oxytocin augmentation in normal labour 
The incorrect use of oxytocin augmentation must be further investigated and 
discussed and together with underlying reasons for unnecessary interventions. 
Women’s knowledge and participation in decisions regarding interventions 
have not been studied sufficiently. 
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